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Preface
The domestication of plants and animals is 
a long and on-going process that has shaped not 
only the domesticated species and the landscape, 
but also the humans who have domesticated 
them. For example, the evolution of our im-
mune system has been strongly influenced by the 
close contact between humans and domestic ani-
mals. The changes in domesticated species have 
been dramatic, from the wild Red Junglefowl 
hen raising two clutches of 10 chicks per year 
to today’s laying hen producing more than 300 
eggs per year. In one hundred years the average 
wheat yield has increased from 2 tonnes per hec-
tare to 6 tonnes per hectare in many European 
countries. Although part of this increase is due 
to management techniques, fertilizers, and pes-
ticides, the genetic component of such progress 
has been substantial.
With an increased knowledge of evolution, 
the understanding of heredity, and the discovery 
of chromosomes and genes, we have gone from 
unintentional selection to advanced breeding 
programmes. Our ever-increasing knowledge 
of the mechanisms behind different traits can 
be used to customize the sources of our food. 
Thanks to these breeding programmes, we now 
have access to healthier livestock and crops, and 
are producing milk, meat, and grain at levels our 
ancestors could only have dreamed of.
With this book we wish to provide an 
overview of the methods and techniques 
used in the domestication and development 
of new agricultural crop varieties and breeds 
of livestock. We also give examples of the 
economic aspects, legislation, and different 
ethical views on the use of biotechnology in crop 
and animal breeding and give an overview of 
products produced through genetic modification. 
This book is published within the Mistra Biotech  
research programme that is financed by the Swedish 
Foundation for Strategic Environmental Research 
(Mistra) and the Swedish University of Agricultural 
Sciences (SLU). We are grateful to Inger Åhman and 
Marie Nyman for helpful comments on the manuscript.
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Agricultural scene from the tomb of Nakht in Egypt (14th century B.C.).
7000-9000 BC
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The history of breeding 
Plant breeding began unintentionally 
about 7000–9000 B.C. when people began sow-
ing seeds instead of just collecting seeds from 
wild plants. The plants that yielded a better 
harvest were the ones that were propagated year 
after year, and thus natural selection was re-
placed with artificial selection by human hands. 
With the change from a nomadic lifestyle to one 
of village life based on plant cultivation, hunt-
ing in the areas around the villages decreased 
the wild animal populations and motivated the 
husbandry of mammals and poultry. The first 
animal to be domesticated was the dog, some 
10,000 years ago. Fear of humans and aggres-
sive behaviour were probably the first traits to 
be selected against. As humans started to choose 
parent animals, traits such as body size could also 
be selected for. 
One of the most problematic traits when 
domesticating a crop is seed shattering in which 
mature seeds drop to the ground or are dispersed 
by the wind or by animals. This trait is crucial 
for survival in the wild but is useless when 
trying to harvest the crop. Consequently, seed 
shattering was one of the first traits to be selected 
against in the early stages of crop domesti-
cation. Collection of seeds from superior plants 
continued and agriculture evolved. Irrigation, 
removal of weeds, and fertilization altered plants 
even further from their wild relatives because 
they no longer had to compete for water, sun, 
space, and nutrients. However, it would be a 
very long time before we began to understand 
the mechanisms behind these changes. 
In the middle of the 19th century, the theory 
of heredity was presented and it was discovered 
that “pure lines” of crops could be created by 
inbreeding (see page 34). At the same time, 
Gregor Mendel showed that traits such as seed 
shape, seed colour, and plant height are inherited 
in a specific pattern in peas. Unfortunately, it 
was not until 40 years after his discoveries that 
the importance of his work was realized. In 
contrast, the entire edition of Darwin’s book 
On the Origin of Species was sold out shortly after 
it was printed in 1859. Darwin understood that 
traits important for survival and reproduction are 
inherited, that there is a variation in the ability 
to survive and reproduce, and that there is a 
limitation in resources so that not all individuals 
that are born will survive. By combining these 
three insights, he could explain the principles of 
evolution as well as the selection of domesticated 
species even though he did not know about genes.
As more controlled crossings between breeds 
or varieties were made, the phenomenon of 
heterosis, or hybrid vigour, was discovered. 
Heterosis is when the progeny of a cross 
1600 1700 1800 1850
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outperform both parents, and this effect is for 
example noticeable in traits related to disease 
resistance in animals and to biomass in plants. A 
decade after the discovery of heterosis, the fact 
that many traits depend on many genes, so called 
quantitative traits, was understood and statistical 
models were developed to account for such traits 
in livestock breeding.
As with evolution, breeding is dependent 
on genetic variation and the recombination 
of genes. However, genetic variation can be 
more or less restricted, especially in crops. 
Also, a desired trait might be closely connected 
to undesirable traits and, therefore, selection 
for a desirable trait can result in selection for 
undesirable traits as well. The discovery that the 
mutation rate could be increased has become 
a useful tool in plant breeding. The use of 
X-rays and toxins can increase mutation rates by 
thousands of fold. Few of the plants will survive 
such treatment, but with a bit of luck one can 
get rid of bad traits or acquire new traits in those 
that do survive, hopefully without detrimental 
changes to the rest of the genome. Most of the 
barley varieties currently under cultivation 
have genes that have been changed by induced 
mutation, and today there are over 2,500 known 
plant varieties that have been developed by 
induced mutation. 
In animals, such a method of breeding is 
not possible due to both ethical and economic 
concerns. Instead, a system of data collection and 
statistical analysis was developed to separate the 
effects of the environment on the desired traits 
from the effects of the genes. This enabled the 
estimation of “breeding values” for all animals. 
Since then, animal breeding has been dependent 
on statistical analysis and has benefitted from 
increasing amounts of data and the development 
of powerful computers. 
The numbers of offspring are low among 
animals compared to plants, but with artificial 
insemination (AI) breeders found an effective 
way get many more offspring from one male 
than would be possible for natural mating. The 
1900 1910
Gregor Mendel, known as the “father of modern  
genetics”, cultivated about 29,000 pea plants during 
his studies on inheritance. Photo: Wikimedia Commons.
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Plant tissue culture is a method where plant tissues can be induced to regenerate a new plant. This is an important 
tool in plant breeding.
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first AI experiments were performed in dogs in 
1780, but it was not until the beginning of the 
20th century that the method was developed for 
practical use.
Spontaneous chromosome doubling, which 
often results in larger plants, had been noticed in 
wild species, but it was not until the beginning of 
the 1930s that a substance called colchicine was 
found to stop the chromosomes from separating 
prior to cell division. Now breeders had a tool 
with which they could increase the number of 
chromosomes in crops and thereby produce larger 
plants. 
In parallel with the breakthroughs in genetic 
research, the first steps were taken toward 
growing plants from cells in a growth medium, 
i.e., tissue culturing, which has become an 
important technique in modern plant breeding. 
Two major advances were test tube fertilization, 
which overcame barriers of sexual reproduction, 
and the ability to regenerate plants from single 
somatic cells (non-germ cells), which meant that 
small amounts of tissue could be used to raise 
thousands of plants. 
Because Mendel studied qualitative traits 
– such as colour and seed shape – that are 
governed by a few genes and Darwin studied 
quantitative traits – such as growth rate – that 
are governed by many genes, their theories at 
first seemed to be in conflict. It was not until 
the 1930s that scientists began to understand 
how traits are inherited. With the discovery that 
genetic material is carried by deoxyribonucleic 
acid (DNA), and the structure of the molecule, 
pieces fell into place. 
Years earlier, the ability to fixate nitrogen 
from the air was discovered, but this knowledge 
was used to produce explosives during World 
War I before it came to be used for producing 
fertilizers on a large scale. Fertilizers had a huge 
impact on agriculture and plant breeding, and 
the green revolution with modern agricultural 
production techniques had begun. Norman 
1960
There are many examples of polyploid plants in nature. 
With colchicine, breeders can increase the number of 
chromosomes in crops, such as the red clover shown here.
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1970 1980
The first organism to be genetically modified was a bacterium. Today, insulin is produced by bacteria that have 
had the gene coding for insulin inserted into a plasmid (a small circular piece of DNA). 
insulin
Modified bacteria  
multiplying
HUMAN CELL BACTERIAL CELL
Gene coding for 
human insulin
12 
Borlaug developed improved wheat varieties, 
and the increased use of herbicides also provided 
incentives to breed for herbicide tolerant crops. 
In the beginning of the 1970s, cells from two 
tobacco species were fused and the first somatic 
hybrid plant was produced. The knowledge 
about cell functions and gene regulation 
increased, and with the ability to use restriction 
enzymes, the cell’s built-in “scissors”, came the 
ability to cut specific genes out of the DNA. 
This was one important tool that led to the 
construction of the first recombinant organisms, 
including the transgenic bacteria that still 
provide us with insulin today. 
In the beginning of the 1980s, researchers 
managed to create the first transgenic plant, 
a tobacco plant, with the help of the soil 
bacterium Agrobacterium tumefaciens. In nature, 
this bacterium causes plants to grow tumours 
by inserting its DNA into the plant’s genome, 
but now those genes could be replaced by any 
other gene of interest. Not all plant species were 
susceptible to infection by the bacterium, so 
other methods were developed such as the gene 
gun with which the desired DNA could be shot 
into the plant. Soon genetically modified (GM) 
plants appeared around the world, first in field 
trials then as commercial crops. 
At the same time, AI of sows became routine 
and methods for embryo transfer were estab-
lished in dairy cows to enable those with the 
best breeding values to produce more calves. 
The first GM animal was a mouse that received 
genes important for growth from a rat, but the 
application of GM technology for commercial 
breeing of farm animals has been limited, 
for ethical and economic reasons. In animal 
breeding, researchers have focused on estimation 
of breeding values and the use of gene maps 
that provide information about the location and 
arrangement of specific genes on a particular 
chromosome (see page 28). The gene maps are 
full of genetic markers that do not themselves 
govern any particular traits but can be used for 
selection if they are located close to genes that 
do affect important traits. Today, selection with 
the assistance of one or multiple genetic markers 
is used both in plant and animal breeding. 
Since the first farm animal (the chicken) had 
its full genome mapped (i.e., its entire DNA 
sequence was described), most of the domesti-
cated livestock species have had their genomes 
mapped.
The first steps from the random mutation 
breeding by radiation or chemicals to precise 
alterations through site-directed mutagenesis 
were taken about 40 years ago, but it has only 
been in recent years that these new methods 
have been sufficiently refined for use in 
commercial applications. However, public 
acceptance of the use of gene technology in 
agriculture has not been as large as for medical 
applications.
1980
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A herbicide tolerant tobacco plant was the first genetically modified plant to be grown in field trials (1986).
1990 2000
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The building blocks of life
Why do we and all the plants, animals, and 
other organisms around us look and behave the 
way we do? In this chapter, we briefly explain 
the structures and mechanisms that are the basis 
for living organisms and focus particularly on 
plants and mammals.
CHROMOSOMES
One can find flower seeds tinier than the period 
at the end of this sentence. In these seeds, just 
like in animal cells, one finds the genome, that 
is, all of the genes. They make the seed germi-
nate and grow into a plant with a specific size 
and shape that thrives in a specific environment, 
flowers at a certain time, and has a certain scent. 
All of the information that is needed to regulate 
the plant’s life has to be stored in that seed. 
Genes are arranged in structures called 
chromosomes that, in mammals, come in 
pairs. Such organisms are known as diploids. 
For example, the domesticated pig has 19 
chromosome pairs with each pair consisting 
of one chromosome from the father and one 
chromosome from the mother. Genes governing 
the same traits on corresponding chromosomes 
are called alleles. In a homozygote, the alleles 
are the same on both chromosomes and in a 
heterozygote the two alleles are different. How 
the different alleles together affect a trait depends 
on whether the individual alleles are dominant 
or recessive (such as the case for brown or blue 
eyes) or if they have an additive effect (such as 
the case for height) (see also the section Genotype 
and phenotype on page 18).
Many plants have more than two sets of 
chromosomes, that is, they are polyploids. 
Autopolyploids are the result of chromosome 
doubling within the same species, and an allopoly-
ploid is a result of chromosome doubling through 
a combination of two different species. For 
example, durum wheat is allotetraploid (it has two 
sets of paired chromosomes) that originated from a 
hybridisation between wild grasses. A hybridisation 
between durum wheat and some wild diploid 
grass resulted in today’s hexaploid bread wheat that 
carries three sets of paired chromosomes.
GENES AND PROTEINS
As stated above, genes are made up of DNA. 
DNA comes as a double helix and looks like a 
spiral-shaped ladder where every rung is made 
up of pairs of the four nucleic acids adenine 
(A), guanine (G), cytosine (C), and thymine 
(T). The nucleotides are often referred to as the 
“bases” of the DNA. The A nucleotide is always 
paired opposite a T and the C nucleotide is always 
paired opposite a G such that the two strands of 
the “ladder” are the mirror of each other.  Pigs have 38 chromosomes, 19 from each parent.
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DNA is tightly packed into chromosomes by proteins. These proteins can unwrap the chromosome to expose the 
bare DNA strands and allow the transcription machinery to copy it in a very precise manner. Using one of the 
DNA strands as a template, an enzyme constructs a messenger ribonucleic acid (mRNA) molecule. The mRNA 
differs from the DNA in that it is single stranded and instead of thymine it contains uracil. The mRNA is 
translated into a protein by another set of protein molecules. Sophisticated modulations and regulations at this 
level are unique to complex organisms like animals and plants compared to simple organisms such as bacteria. The 
mRNA is translated, according to the genetic code, into a specific sequence of amino acids that are then folded into 
a functional protein.
Nucleus
CELL
Chromosome
Base pair
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The order in which the bases appear determines 
which amino acid they code for. The code for an 
amino acid is made up of three bases. For exam-
ple, the three bases AAG code for lysine. 
Proteins are responsible for almost all processes 
that occur in all living organisms, for example, 
enzymes and many hormones are proteins and 
muscles consist mostly of protein. Proteins are 
built of amino acids and it is the unique combi-
nation and sequence of the amino acids that 
determines the structure and properties of the 
protein such as its heat sensitivity, if it binds 
to other specific proteins, or if its shape and 
function are altered with changes in pH.
GENETIC CHANGE
The success of all species in terms of survival 
and propagation depends on their ability to 
adapt to new and changing environments. High 
genetic diversity increases the probability that 
some of the individuals in a population will have 
characteristics that are advantageous in certain 
environments and, therefore, will be better able 
to cope with changes in the environment than 
other individuals. Mutations and recombination 
between the chromosomes lead to the genetic 
diversity that is crucial for evolution.
REPRODUCTION
Genes code for the production of proteins and 
they transfer this information to the new cells 
when cells divide. Unicellular organisms like 
bacteria reproduce by a simple cell division. 
Bacterial genes are arranged on a single circular 
chromosome as well as on small rings of DNA 
or RNA called plasmids. Animals and plants, on 
the other hand, are built of many cells each hav-
ing specialized functions, and some of these are 
specialized reproductive cells known as gametes. 
These cells are formed in two steps. In the first 
step, each chromosome is copied and the two 
doubled chromosomes (for a diploid organism) 
are lined up next to each other. At this stage 
pieces of the DNA strands on the correspond-
ing chromosomes can switch place with one 
another in a process known as recombination. 
This crossover process results in offspring with 
a genetic makeup that is different from both of 
the parents. In the second step, the chromosome 
pairs move in separate directions after which the 
cell divides once and then a second time result-
ing in gametes with half the number of chromo-
somes. In a diploid species, the gametes will have 
just one of each chromosome. When the female 
gamete is fertilized by the male gamete, the new 
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individual receives half of the mother’s genetic 
makeup and half of the father’s to create a new 
individual with a unique set of genes. 
There are examples of animals that can 
reproduce asexually, such as aphids, and 
many plants can multiply vegetatively (i.e., 
non-sexually) through bulbs (garlic), tubers 
(potatoes), or stolons/runners (strawberries).
MUTATIONS
Any of the bases A, T, C, or G can be exchanged 
for another base and this is known as a muta-
tion. For this mutation to have any effect, the 
base has to be located in a gene or a region that is 
involved in the expression of a gene. In addition, 
the change in the base has to change the amino 
acid that is coded for. Also if the amino acid is 
changed, such a change must alter the protein’s 
function in some way for the mutation to have 
an effect. Most mutations in the genome are 
repaired by the cell, but if a mutation occurs in 
a gamete and is not repaired the change will be 
inherited in the next generation.
Many mutations in gametes are harmful, and 
some are so harmful that the offspring never 
develops. Even so, mutations are crucial for 
the process of evolution, and a small portion of 
these mutations are beneficial for the individual 
organism’s ability to survive and reproduce. 
Depending on to what extent the mutation 
affects the individual’s fitness, the new allele 
might become more and more common in the 
population with each generation. Established 
mutations in combination with the mixing of 
the parents’ chromosomes and the recombination 
of genes, increases the variation in traits. This 
helps populations of organisms adapt to new 
conditions because these genetic variations often 
result in some individuals that manage better in 
the new environment. If a population is isolated, 
this development might eventually result in the 
establishment of a new species. In breeding, 
humans make use of such genetic variation 
to make selections based on which traits are 
preferred in crops and livestock. 
GENOTYPE AND PHENOTYPE
An organism’s genetic makeup is called its 
genotype. An organism’s appearance is called 
its phenotype. The genotype can include many 
genes with “hidden” effects such as recessive 
alleles in a heterozygote, thus two individuals 
that look the same can have different genotypes. 
For example, two black sheep can have the same 
phenotype – they both have black wool – but 
one can have the genotype BB and the other can 
have the genotype Bb. In this case, the B (black) 
allele is dominant over the recessive b (brown) 
Recombination of genes during meiosis. When the gametes 
(sperm and egg cells in animals) are formed, each chro-
mosome pair exchanges some parts of their DNA before 
they separate. Which parts of the chromosomes recom-
bine varies, and sometimes the exchange is imbalanced 
and this can have detrimental effects on the organism.
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allele. This means that a sheep has to get the 
“b” allele from both its parents (it would need 
to have a bb genotype) in order to have brown 
wool. Most traits are more complex than this 
and are based on the interactions of several genes 
that can lead to a wide variety of phentoypes. 
Many traits are governed by numerous genes 
with additive effects, and this results in offspring 
that have phenotypes that are combinations or 
intermediates between those of the parents. Most 
of the phenotypic traits are inherited in this 
way and it is not possible to distinguish specific 
genotypes by simply looking at an individual. 
Instead, one can only estimate the genotype 
based on the organism’s phenotype and the 
phenotypes of its relatives. To make it even more 
complicated, the phenotype s often also affected 
by environmental factors.
GENES AND THE ENVIRONMENT
The phenotype of an organism cannot be ex-
plained solely by the genotype of the organism. 
In fact, the observed phenotypic trait is often the 
result of the expression of the genes influenced 
by a given environment. For some traits this 
expression is quite stable across a wide range of 
environments, but other traits show considerable 
variation with specific environments. When a 
genotype results in different phenotypes in dif-
ferent environments, this is called a “Genotype 
by Environment” interaction. For example, such 
interactions can be relevant for the maternal 
behaviour of sows. Perhaps the sow with the best 
genotype for maternal ability in an intensive 
indoor production system is not the best sow in 
a free-range system. In another example, when 
new spruce trees are planted in the forest the 
genotypes of the plants are chosen depending on 
the region of the forest the trees are planted in. 
For some traits it is easy to predict the offspring’s 
properties based on the parents, but for other 
traits such predictions can be very difficult due 
to the influence of environmental effects. 
EPIGENETICS
Epigenetics is a relatively new and flourish-
ing research area. In the field of epigenetics, 
researchers investigate heritable, but reversible, 
changes in gene expression that are not caused 
by changes in the DNA sequence. In all living 
organisms, parts of the genome are switched on 
and off at specific times in different tissues and 
cells and during different developmental stages. 
This regulation is accomplished by an array 
of chemical reactions, and in some cases these 
changes are carried into the new cells after cell 
division and thus into the next generation. Such 
heritability of epigenetic regulation is considered 
to be an important mechanism by which many 
species can rapidly adapt to changes in their en-
vironment. Epigenetic changes can, for example, 
take place during the first steps of gene regula-
tion during the unfolding of the packed chromo-
somal DNA or by the addition of methyl groups 
to the DNA. From a breeder’s point of view, it is 
important to understand which alleles behave in 
this epigenetic fashion because they will not be 
inherited in the classic Mendelian manner and 
this will hamper the ability to link such alleles to 
different traits. 
The allele for black colour in sheep is dominant over 
the allele for brown. That is why black sheep are more 
common.
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Breeding methods
As described in the first chapter, humans 
have been breeding plants and animals more or 
less intentionally for a very long time. With in-
creased knowledge about how traits are inherit-
ed, a better understanding of molecular genetics, 
and the availability of powerful computers and 
statistical software, new breeding methods and 
technologies have been developed.
ANIMAL BREEDING 
There are two basic questions that animal 
breeders must ask. The first question is to 
define the breeding goals: “Which animal is 
the best animal?” Is it the cow that produces 
more milk, the one that lives longer, or the one 
that combines high milk production with good 
hoof health? Is it the sow that produces a larger 
litter, or the one that has more teats, or maybe 
the one with the best nursing behaviour? These 
questions are open to debate, and no one has all 
the answers, but they address the breeding goal 
and provide the direction of the selection that 
will affect the characteristics of the animals. 
The second question is, “How can we identify 
the best animals in order to improve future 
generations?” This question involves knowl-
edge of animal breeding and genetic principles. 
This chapter will give some answers to both 
questions.
Animal breeding is a long-term, multi-step 
process that aims to improve future animal 
populations. For successful breeding it is 
important to study the genetics of traits and 
to address the question of to what extent the 
variation in a trait between individuals depends 
on the effects of various genes. This describes 
the “heritability” of the trait (see page 23). 
Another part of such a study is to determine 
the extent to which different traits relate to 
each other and to what extent such relation-
ships can be explained by the different genes. 
This is the “genetic correlation” between 
traits. Both heritabilities and genetic correla-
tions must be estimated in order to predict 
the consequences of the breeding programme. 
The next step is to record the traits that 
should be changed, together with unique 
animal identities, and to estimate the animals’ 
breeding values. The best animals – those with 
the highest breeding values – are selected to 
become the parents of the next generation. 
The accuracy of the breeding value depends 
on the available information. In the following 
sections, these steps will be described in 
greater detail.
BREEDING GOAL
The first step is to decide on the breeding goal, 
for example, breeding pigs to be fast grow-
ing and healthy with low levels of aggressive 
behaviour. In cattle, the breeding goal could be 
robust cows that reproduce regularly. The goal 
can be modified over time due to changes in 
the specific needs of the farmers or the market. 
The breeding goal can also differ among differ-
ent organisations within and between different 
countries.
A breeding goal usually seeks the optimal 
combination of several traits. The weight 
given to each trait in the breeding programme 
depends on the heritability of each trait, on the 
genetic correlations between the traits, and on 
the economic value of a change in each of these 
traits. Such weighing factors are called economic 
weights. Many breeding programmes include 
goals related to production traits (such as growth 
rate, milk production, and egg yield), repro-
ductive traits, and health traits.
22 
BREEDING VALUE
A crucial part of every breeding programme 
is to record the traits that should be improved 
together with the animal identities. All this 
information is gathered in a database and used 
in a genetic evaluation of the animals’ breeding 
values. The breeding value predicts how valuable 
an animal will be as a parent. In other words, 
the breeding value seeks to estimate the worth 
of the animal’s offspring. The breeding value 
can be expressed in monetary terms (such as the 
value of the meat produced in euros) or in trait 
units (such as the increase in meat production in 
kilograms). 
The best animals – those with the highest 
breeding values – are selected to become parents 
of the next generation. Thanks to the database, 
which covers all of the relationships between 
animals, it is also possible to estimate breeding 
values of animals that do not have individual 
records. Thus, a ram can have a breeding value 
for maternal behaviour, and a young stallion, too 
young yet for competitions, can have a breeding 
value for dressage.
In dairy cattle breeding programmes, breeding 
values for production (milk yield) and so-called 
functional traits (the ability to become pregnant, 
calf survival, disease resistance, hoof health, etc.) 
are combined with their economic weights to 
create the total merit index that describes the 
animal’s total breeding value based on all of its 
traits. This genetic evaluation is performed by 
breeding companies. The best bulls are selected 
and moved to AI stations where their semen is 
collected and distributed to dairy herds where 
cows are inseminated. Thus genetic progress is 
assisted by AI.
The accuracy of the breeding value depends 
on the amount of information in the database. 
This is especially true for traits with low herit-
For breeding programmes to be successful one needs to keep track of each individual animal and measure several 
factors, both physiological and behavioural.
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Cow Hoof health x
Cow Milk yield x
Dog, sheep & pig Litter size x
Dog, sheep & pig Growth rate x
Fish Salmon flesh colour x
Fox Fear of humans x
Honey bee Honey yield x
Horse Trotting speed, prize money x
Horse & cow Stature (height) x
Human Body height x
Human Verbal ability x
Mouse Ability to find the way in a maze x
Pig % lean meat, live animals x
Pig % lean meat, after slaughter x
Pig Pubertal age x
Sheep Lamb survival x
SPECIES TRAIT HERITABILITY
 low moderate high
Heritabilities for different traits in different species. If the heritability is high, the rate of genetic change from  
generation to generation will be faster.
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The breeding organisation (1) is the hub of this beef-cattle breeding programme. Here all phenotypic and genetic 
information is stored in a database and the genetic evaluation is performed. At the performance-testing centre (2), 
young bulls are tested for traits of interest (e.g. growth rate, etc). After these tests, the bulls with the highest breed-
ing values are moved to an AI station (3) where semen is collected and distributed to many herds. Good bulls, but 
not the very best, are sold to farmers (4) and used for the natural service of cows. The bulls with the lowest breed-
ing values are slaughtered (5). Cows (6) are either inseminated or mated. Most calves are raised for slaughter (7), 
but the best females are selected to become mothers of the next generation (6). Some male calves are sent to the 
performance-testing centre (2). The selection of breeding cows is based on breeding values for maternal traits (e.g. 
calf survival, etc.). Traits such as meat quality can only be measured after slaughter and thus cannot be measured 
in selection candidates. Instead, trait records and animal identities are collected on relatives of the selection candi-
dates at the slaughterhouse (7).
  
ability, including reproductive traits like litter 
size and the ability to become pregnant, so it is 
important to collect as many records as possible. 
Some traits (like appetite or egg weight) can be 
recorded several times on the same animal, but 
others (like age at puberty or meat quality) can 
be recorded only once. Bulls used for AI have 
thousands of daughters, and the breeding value 
for the ability of their daughters to become 
pregnant can be estimated with a high level of 
accuracy. The trait leanness (or its opposite, 
fatness) is important for meat production in 
several species. It has a high heritability and it 
was therefore possible to breed for increased 
muscle growth and decreased fat layer long 
before large breeding programmes and advanced 
statistical models were available. Simply 
choosing the leanest animals in the herd and 
using them as parents resulted in rapid genetic 
progress. It would never be as easy to genetically 
improve a trait like piglet survival (which has a 
low heritability) on the herd level. 
CROSSBREEDING
The aim in crossbreeding is to boost hybrid vig-
our or “heterosis”. In a trait with a pronounced 
heterosis effect, the quality of the trait in the off-
spring is better than the average of the trait in its 
parents. Heterosis is especially important for traits 
like survival, reproduction, and health. (You can 
read more about crossbreeding and heterosis on 
page 36 in the section about plant breeding.)
In general, pig breeding has a hierarchical 
structure. Genetic evaluation and selection is 
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The animals with the best breeding value are used as parents for the next generation.
performed in a few special herds with purebred 
animals, and the genetic progress achieved in 
these herds is disseminated via AI to pigs raised for 
slaughter in commercial herds. Most of the pigs 
in commercial herds are crossbred, and thanks 
to heterosis the crossbred pigs are more vital and 
healthier and grow faster than purebred pigs. 
Crossbreeding is also commonly used in other 
livestock species such as laying hens and broilers.
INBREEDING
Inbreeding is the mating of related individuals. 
Inbred organisms have an increase in homozygo-
sity (acquiring the same allele from both parents) 
and exhibit more effects of recessive alleles, 
which are more likely to be detrimental. This 
phenomenon, known as inbreeding depression, 
can significantly decrease the performance of the 
organism. When relatives are mated, the total 
amount of genetic variation in the population 
decreases. A decrease in heterozygosity results in 
reduced production, survival, health, and repro-
ductive efficiency. 
Selection has dramatically reduced the genetic 
variation in some breeds. Today, for example, 
only a limited number of bulls in the Holstein 
dairy cow breed serve as fathers of highly 
influential bulls that are used for AI all over 
the world. In the short term, inbreeding can 
be avoided at the farm by never mating close 
relatives, but the setup of a long-term breeding 
programme depends on correctly selecting the 
young sires entering the test programmes and thus 
on the routines of the breeding organisations. 
Trait improvement
Desired trait(s)
Trait improvement
Desired trait improved!
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ARTIFICIAL INSEMINATION
When selecting the best animals for a breed-
ing programme, one limitation is that one male 
can only mate with a limited number of females 
within a geographically limited area during 
a limited time period. With AI, one collects 
semen from the male and inseminates several 
females. This results in a more efficient use of 
bulls because a single bull can produce hundreds 
of doses from a single semen ejaculate. The 
semen is easy to transport and can be frozen al-
lowing for insemination around the world and 
the ability to store it for long periods of time. 
The possibility to only use a few males as parents 
for the next generation increases the potential for 
genetic selection and the rate of genetic change. 
Another benefit is reduced disease transmission 
between males and females that can occur dur-
ing natural mating. 
For the farmer, AI can also decrease costs and 
increase safety. Maintaining one or more males 
on a farm could be expensive and, depending on 
their size and level of aggressiveness, the males 
could also be potentially dangerous to the farmer. 
EMBRYO TRANSFER 
The number of progeny born to a female can 
be increased through the use of embryo transfer 
(ET). This is a reproduction technique in which 
embryos are collected from a female with a very 
high breeding value (the donor female) and trans-
ferred to other females (the recipient females) that 
serve as surrogate mothers. ET techniques have 
been applied to almost all domestic animals as 
well as many wildlife and exotic species. 
The MOET concept (multiple ovulation and 
embryo transfer) is mainly used to increase the 
speed of genetic change. The best cows are 
moved to a special herd, treated so that they 
ovulate many eggs, and inseminated with semen 
from the best bulls. The fertilized embryos 
are then collected and transferred to recipient 
cows. When the calves are born, they are 
raised, mated, and compared for traits like milk 
production. The best ones are used as parents for 
the next generation. 
Over the past decade, new technologies have been 
developed for the freezing and long-term storage 
of valuable embryos. Such cryo-preservation 
In animal cloning, the nucleus from a somatic cell (non-germ cell) from the animal to be cloned (the cell donor) is 
fused with an egg cell that has had the nucleus removed. The cell divides and develops into an embryo that is then 
placed in the uterus of a surrogate mother.
Cell donor
Egg donor
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can be a complement to the conservation of live 
animals in species and breeds that are at risk of 
extinction. 
CLONING
Embryos from parents with very high breeding 
values have a high economic value. In species 
where only one offspring is born at a time, such 
as cows and horses, valuable embryos can be split 
to get two or even four new embryos. 
Somatic cell nuclear transfer is a cloning 
process where genetic material is transferred 
within a generation, which is in contrast to 
normal reproduction where genes are transferred 
from one generation to the next. With this 
technique, an animal that is a genetic copy of 
another currently or previously existing animal is 
created. The sheep Dolly is the classic example. 
In practice, the nucleus (and its DNA) of a so-
matic cell (a non-germ cell) is transferred from 
a donor to an “empty” egg, that is, an egg from 
which the nucleus, and thus its genetic material, 
has been removed. For example, when Dolly the 
sheep was created the DNA was taken from an 
udder cell. The reconstructed egg containing 
the DNA from the donor animal must be treated 
with chemicals or electric current to stimulate 
cell division. Once the cloned embryo reaches a 
suitable developmental stage, it is transferred to 
the uterus of a recipient female where it contin-
ues to develop until birth. 
Some famous competition horses have been 
cloned by somatic cell nuclear transfer. In this 
way, even genes from castrated horses can be 
propagated. It should, however, be remembered 
that the phenotype, in this case the success 
or failure of a jumping horse, is the result not 
only of the genes but how the horse is raised 
and trained (see page 19 about genes and 
environment). Thus, the buyer of a cloned horse 
might be disappointed with the new animal no 
matter how successful the donor was. 
Animal cloning is also used both in the research 
on and application of therapeutic cloning. The 
goal is to create stem cells that can be used to 
study human development and to treat serious 
human diseases like heart disease, Alzheimer's 
disease, and cancer at the cell or tissue level.
28 
MOLECULAR SELECTION
Most traits that are important in animal produc-
tion seem to have a quantitative genetic back-
ground in which many genes, each with a small, 
additive effect, influence the final result. Some 
traits, however, are governed by single genes. For 
example, in pigs the low ability to handle stress 
(Porcine Stress Syndrome) is caused by a mutation 
in a single gene. A similar example is a recently 
discovered mutation in horses that influences 
movements and, therefore, the horse’s potential 
success as a trotter. If a gene with a large effect on 
an important trait is identified, individuals can 
be selected based on molecular analysis of their 
DNA. Even when the gene coding for the rel-
evant characteristic is not known, DNA analysis is 
helpful if there is knowledge about gene mark-
ers – DNA sequences at known locations that are 
linked to the genes of interest. The genetic mate-
rial for such analysis can be provided by biological 
samples such as blood, hair follicles, or anything 
else with cells containing DNA.
In 2005, the chicken was the first farm ani-
mal to have its full genome mapped, that is, 
its entire DNA sequence was described. Full 
mapping does not mean that the function of 
all genes is known, but the map can be used 
to identify individuals with desired charac-
teristics (see page 30-31). The amount of data 
in a genome is very large. For example, there 
are approximately 6 billion base pairs in the 
human genome, and these are stored on high-
speed computers with large storage capacities. 
The full sequence of a cow genome was com-
pleted after six years of work by more than 300 
scientists in 25 countries. It was found that out 
of 22,000 genes in the cow genome, 14,000 
were in common with all mammalian species, 
including humans. The list of species that have 
had their genomes fully sequenced is long and 
is constantly growing. 
Domestic animals that have had their genomes fully sequenced. 
COMMON NAME SCIENTIFIC NAME YEAR
Cat Felis silvestris catus 2007
Chicken Gallus gallus 2005
Cow Bos primigenius taurus 2009
Dog Canis lupus familiaris 2005
Horse Equus ferus caballus 2009
Pig Sus scrofa 2012 
Rabbit Oryctolagus cuniculus 2010
Yak Bos grunniens 2012
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A genetic linkage map of rice 
chromosome number 8. Linkage maps 
show the positions of genes and genetic 
markers on a chromosome. The order and 
distance between the genes and markers 
on the map are based on their recombi-
nation frequency rather than their actual 
physical distance. If two genes or markers 
have a high recombination frequency (i.e., 
they segregate often), they are assumed to 
be far apart.
(With permission of the Nature
Publishing Group)
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QUANTITATIVE TRAIT LOCI
“Quantitative trait loci” (QTLs) are regions 
of the DNA sequence that are located close to 
genes that have a significant effect on a quan-
titative trait, for example, maternal behaviour 
or growth rate. Although many genes govern 
such traits, some of the genes might be more 
important than others. There are often several 
QTLs for a particular trait, and they can even 
be located on different chromosomes. Knowing 
the number of QTLs that have an influence on a 
trait, and the significance of each of these QTLs, 
provides information about the genetic architec-
ture of that trait. It must, however, be remem-
bered that the QTLs only give the approximate 
locations of interesting genes; they explain noth-
ing about how traits are governed or the physi-
ological background of the traits. 
Finding a QTL is often the first step in 
locating one of the genes that is influencing a 
trait. The QTL points to a region of DNA on a 
chromosome, and this region can then be fully 
sequenced. This DNA sequence can then be 
listed in a database and compared to other genes 
whose function is already known. Comparisons 
between species are very useful for this work 
because large parts of the genome have been 
conserved during evolution.
MARKER-ASSISTED SELECTION 
Some parts of the DNA sequence show a large 
variation between individuals. Individuals with 
different values in a trait often have specific dif-
ferences in their DNA sequences that co-vary 
with the differences in the trait. If a certain DNA 
sequence is found to be related to an impor-
tant characteristic (such as an increased risk of 
a disease), individuals carrying that sequence 
can be culled. Such identified DNA sequences 
are called markers, and this selection method is 
called marker-assisted selection. The idea behind 
marker-assisted selection is that the marker can be 
used to identify individuals carrying a favourable 
allele (or to cull those carrying an unfavourable 
allele) even if the actual gene or genes coding for 
the characteristic itself have not necessarily been 
identified. 
Marker-assisted selection is used in many 
breeding programmes as a complement to 
genetic evaluation. Due to the crossover between 
chromosomes when germ cells are created, 
markers that are useful in breeding for one breed 
are not necessarily useful in another breed. If a 
marker is located very close to the (unknown) 
gene of interest, however, it is unlikely that there 
will be a crossover between the marker and 
the gene. Thus the accuracy of marker-assisted 
selection is better the more markers (and fewer 
gaps between markers) there are. 
GENOMIC SELECTION
Genomic selection makes use of genetic mark-
ers covering the entire genome. The markers 
used here are “single nucleotide polymorphisms” 
(SNPs) each consisting of single points in the 
DNA sequence where the nucleotide (A, T, C, 
or G) is highly variable between individuals. 
Genomic selection is a two-step process. First, 
the association of genetic markers with the trait 
of interest is established in animals along with 
phenotypic information, and a genomic breed-
ing value is estimated for these animals. Such a 
group of animals with both desired phenotypes 
and genomic breeding values are called the 
training population or reference population. In 
the second step, animals from the next genera-
tion, the selection candidates, are genotyped and 
their genotypes are compared to those from the 
training population. This will then allow for 
an estimation of their genomic breeding value 
and will thereafter allow for selection of young 
animals for breeding based solely on their SNP 
marker information. If genomic selection can be 
successfully applied in a breeding programme, it 
will allow an early selection of the best breed-
ing animals and improve genetic progress due 
31 
to the reduced time required for the selection 
process. Genomic selection is currently used in 
dairy cattle breeding populations and has been 
highly successful, especially in the breeding of 
Holstein Friesian cattle. This approach allows for 
the selection of bulls for breeding as soon as they 
are born. Using phenotype-based methods would 
require waiting until year 6 when phenotypic data 
(like milk yield) would become available from the 
young bull’s daughters.
For information about proteomics and metabolomics, 
see page 39 in the chapter about plant breeding.
GENETIC MODIFICATION IN ANIMALS 
Genetic modification through transformation is 
similar in animals and plants. The first transfor-
mation method developed for animals was based 
on microinjection of DNA into the nucleus of 
a newly fertilised egg. The egg cells that sur-
vived the process were then transplanted into 
the uteruses of recipient females. This technique 
was used to produce the first transgenic livestock 
almost 30 years ago, and since then many GM 
animals have been bred. The microinjection 
technology is, however, rather inefficient and 
often leads to undesirable side effects caused by 
the random integration of new genes. 
The list of alternative techniques is long. One 
method is sperm-mediated DNA transfer that 
makes use of the ability of spermatozoa to bind 
and take up DNA before fertilizing the egg. 
A promising tool is to use viruses as vectors 
for DNA injection into eggs. Some types of 
viruses – called retroviruses – have the ability to 
integrate their genomes into the genomes of other 
species. Humans, for example, have many such 
DNA elements in their genome that have been 
incorporated during evolution and have seldom 
negative effects. By transferring vectors derived 
from retroviruses into young embryos, DNA 
coding for specific proteins can be transmitted 
to animals. These founder animals are then used 
as parents of a population of GM animals with 
new traits, for example, animals that produce 
hormones for medical treatment in humans.
By gel electrophoresis DNA molcules can be separated depending on their size. You can then cut out the “band” 
of interest and sequence the DNA. 
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PLANT BREEDING
Just as with livestock, plants are bred to be resist-
ant or tolerant to diseases, insect pests, or other 
organisms that damage the plants. Crops are also 
bred to allocate their resources to plant parts 
that give us a high yield of for example seeds 
and fruits. To make the most use of these crops, 
especially grains, the crops are bred to mature in 
time and to grow in such way that they are easy 
to harvest, and to resist pests and disease during 
storage.
With the availability of more efficient 
machinery and herbicides, there has been a 
reduced need to develop crops that can compete 
with weeds. Furthermore, crops with herbicide 
tolerance have been developed so that weeds 
can be controlled without harming the crop. 
Although efforts have been made to breed for 
resistance against pathogens, insect pests, and 
the diseases that they might spread, the use of 
fungicides and insecticides have offered an easy 
and quick solution in many cases. Also, cheap 
fertilizers and a lack of knowledge about the 
consequences of nutrient leaching have not 
encouraged breeding for more efficient nutrient 
uptake. However, modern environmental 
Brassica oleracea comes in many shapes and colours, for example cabbage, broccoli, cauliflower, and brussels sprouts.
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With molecular knowledge you can select the best individuals at an early stage and this will likely shorten the 
breeding process for trees.
requirements for reduced use of fertilizers, 
herbicides, and pesticides have led to shifts in 
breeding goals.
Breeding of annual crops is not necessarily 
quicker than animal breeding, despite the shorter 
generation interval, because of the numerous 
breeding cycles that are required to get a crop 
of high quality. Breeding of trees involves even 
longer generation intervals than for animals 
like cattle and horses. There are several ways 
to improve plants depending on their mode 
of reproduction, breeding goals, and financial 
constraints. 
PLANT BREEDING SYSTEMS
Plant species can be roughly divided into the 
following three groups based on their mode of 
reproduction: self-pollinators, cross-pollinators, 
and vegetative propagators. The majority of an-
nual crops of agronomic importance are propa-
gated by seeds and are self-pollinators. These 
are partially or fully self-fertilizing plants that 
can be easily used to create “pure lines” that 
are homozygotes carrying the same alleles for a 
gene on both chromosomes. Almost all cross-
pollinators are biennial or perennial species that 
are not adapted to homozygosity, to the same 
extent as self-pollinating species, which results 
in lost vigour if inbred. However, even strict 
cross-pollinators can be self-fertilized by various 
techniques. Many plants can also be propagated 
(multiplied) by tubers (like potatoes) or cuttings 
(like willows), which simplifies the breeding of 
these species. A large number of offspring and 
less time required for management enables plant 
breeders to work with larger populations com-
pared to animal breeders.
MASS SELECTION
Mass selection is the oldest form of plant breed-
ing and has been used by humans for millennia 
since we began collecting seeds to be sown. This 
method still finds use in certain species, especial-
ly in cross-pollinating plants. With this method, 
one collects the seeds from selected individuals 
in a population and the next generation is sown 
with the mixed seeds. An alternative method has 
been to remove all plants with undesired traits 
in the field prior to seed collection. Many old 
and traditional plant varieties have been improved 
this way, and the varieties have been passed down 
from one generation of farmers to the next.
34 
PURE-LINE SELECTION
Pure-line selection is usually only practiced in 
self-pollinating plants, but it can sometimes be 
applied after crossing in cross-pollinating plants. 
With this method, one selects numerous superior 
plants whose offspring are monitored separately, 
often for several generations. Promising lines 
are then further evaluated and the exception-
ally good ones are released as new varieties. The 
early success with this method depended on the 
high genetic variability found in many of the 
landraces. For pure-line selection to be effective, 
one needs a population with high genetic vari-
ability which makes this method less important 
in the development of the major crops today. 
However, the method is still used in breeding 
less heavily selected species. 
HYBRIDIZATION
This breeding method normally starts with the 
crossing of two lines with desirable alleles in 
order to produce progeny that are superior to the 
parents. Depending on how different the genetic 
makeup is between the two parents, billions of 
different genotypes are possible in the second 
generation (the first generation will all have the 
same genetic makeup consisting of half from 
each homozygotic parent). Depending on the 
reproduction system, among other things, the 
hybridization is followed by different selection 
schemes.
PEDIGREE BREEDING
Pedigree breeding involves crossing two geno-
types, each carrying one or more desirable traits 
that are lacking in the other. If the two parents do 
not provide all of the desired traits, a third parent 
can be included by crossing it with one of the 
progeny from the first generation (F1). Superior 
individuals are selected over several generations. 
The first selection in pedigree programmes is 
often made in the second generation (F2), which 
shows large variation because they are heterozy-
gous for many genes. This step is usually focused 
on eliminating plants with undesirable alleles 
that have a clear effect on the trait such as low 
resistance against a specific disease. Self-pollinated 
plants enable pure-line selection until almost total 
homozygosity is achieved, usually in the fifth 
generation (F5). At this stage, seeds from the se-
lected lines are harvested in bulk to produce seeds 
for field trials, and at about the seventh or eighth 
generation the focus is on a more precise evalua-
tion of plant quality and performance. 
BULK POPULATION BREEDING
This method differs from the pedigree method 
primarily in the way the hybrid offspring are 
handled. In this method, the F2 generation is 
sown in a large plot and seeds are harvested all 
VARIETY B
VARIETY A
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together. These are then sown in a new plot 
without keeping track of their ancestry. Plants 
with low survival rate are eliminated by natural 
selection, and plants with other undesirable traits 
are often removed as well. Sometimes seeds are 
harvested at an early stage to select for early ma-
turing plants. These steps are followed by single 
plant selection and evaluation in the same way 
as in the pedigree method. The advantage of the 
bulk population method is that one can screen a 
very large number of individuals at low cost.
BACKCROSSING
Breeding commonly starts with a good variety 
that just lacks one specific trait, such as resistance 
to a specific pathogen. One way of introducing 
this trait is to use backcrossing. To start with, 
one needs to find a plant that carries the desired 
trait and that can be crossed with the variety that 
is lacking the trait. The chances for backcross-
ing to work are higher if the trait is coded for by 
just one or a few genes. After the first crossing 
and propagation, plants with the desired trait are 
selected and these are crossed again with a plant 
of the original good variety. This is usually re-
peated five or six times to produce a hybrid with 
all of the original traits and now also includ-
ing the new desired trait. The advantages of this 
method are the small number of plants needed in 
each generation and that it is fast and predictable. 
The disadvantage of this method is that the de-
sired genes might be tightly linked to less desired 
ones, and this lowers the probability of separating 
them no matter how many backcrosses are made.
Backcrossing is used to introduce a specific trait into a plant line without ending up with other unfavourable 
characters. After the initial crossing, the best offspring are crossed with the original plant line (B) until a hybrid is 
produced with all of the desired traits. 
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HYBRID VARIETIES
Hybrid varieties are not the same thing as varieties 
produced by hybridization, and this is often con-
fusing. In the process of producing hybrid varieties, 
selected plants are first inbred for several genera-
tions to create individually purebred lines. These 
purebred lines are then crossed. A cross between 
two specific homozygotes always results in the 
same genetic makeup, which means that once the 
purebred lines that give the best hybrid have been 
identified the new variety can be continuously pro-
duced. Another advantage with hybrids is hybrid 
vigour, or heterosis, which can result in increased 
growth rate, earlier flowering, and increased yield. 
This is due to the fact that many disadvantageous 
characteristics are coded for by recessive alleles, 
and the high heterozygosity in the F1 generation 
decreases the probability of getting two unfavour-
able alleles for the same gene. However, if the seeds 
are re-sown, the next generation (F2) will consist 
of very diverse plants with average yeilds far below 
the F1 generation. This means that seed from hy-
brid varieties is poor as planting stock and farmers 
must buy new hybrid seed each year. 
SYNTHETIC VARIETIES
A synthetic variety works like mass selection 
with the exception that all crosses are made 
between plant lines known to give superior 
offspring regardless of how they are combined. 
They give hybrid vigour and usable seeds for 
coming seasons. Many synthetic varieties are 
forage crops for which the production of hybrid 
varieties would be too costly. 
Hybrid varieties – the maize example
The development of hybrid maize has had a 
huge impact on increasing its yield and is a 
prime example of the strong effects of hybrid 
vigour. Maize is pollinated by the wind that 
blows pollen from the tassels to the styles, 
and controlled crosses can, therefore, easily 
be made at the field scale by planting one row 
with parent plants providing the pollen and 2 
or 3 rows of the seed parents from which the 
tassels are removed before they shed their 
pollen. To avoid the problem of low-producing 
inbred lines, most hybrid maize is produced by 
first crossing four inbred lines in pairs (A × B 
and C × D) and then crossing their offspring 
(AB × CD). In this way seed production 
becomes more efficient, which lowers the 
seed price. Instead of removing the stamens 
(the tassel at the top) by hand, one can use 
male-sterile plants that are unable to produce 
functional pollen. Hybrid (left) compared to  
non-hybrid (right) maize.
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MUTATION BREEDING
Mutations are changes in the nucleotide se-
quence of an organism caused by errors in the 
replication process, radiation, or chemicals. Al-
though mutations occur at a very low frequency 
in nature, they create sufficient genetic variation 
to drive evolution. Traits might change or disap-
pear or new traits might be introduced. One way 
to increase genetic variation is to speed up the 
mutation rate. Chemical mutagenesis involves 
treating the seeds with a toxic chemical agent, 
for example, ethyl methanesulfonate (EMS) or 
dimethyl sulphate. Depending on the chemi-
cal, the changes in the DNA can be more or less 
specific. For example, EMS commonly leads to a 
change from a G-C base pair to an A-T base pair. 
Radiation can break chromosomes and produce a 
wide variety of altered nucleotides. The com-
mon radiations used are X-rays and gamma rays. 
Rapeseed, barley, cotton, and rice are examples of 
crops in which mutation breeding has been used.
The problem with mutation breeding is that 
mutations happen randomly and most of the 
mutations are undesired. This makes selection 
of the desired phenotypes more difficult, time 
consuming, and expensive. Thousands of plants 
might be needed before a viable individual 
with the desired genetic changes is found. 
Another disadvantage to this method is that 
other important genes can also be mutated, and 
this requires additional breeding, for example, 
by backcrossing, to restore the plant line to its 
original quality.
CHROMOSOME DOUBLING 
As described earlier, many plants have more than 
two sets of chromosomes, that is, they are poly-
ploids. Polyploids usually have more biomass or 
larger fruits and seeds than diploids, and this is 
often desirable. Potatoes and bananas are exam-
ples of autopolyploids (all of their chromosomes 
originate from the same species). Allopoly-
ploids carries a combination of chromosomes 
from different species. For example, rapeseed is 
an allopolyploid from the crossing of a cabbage 
and a turnip. 
If a diploid is crossed with a tetraploid, the 
offspring will be triploid (one chromosome set 
from one parent plus two sets from the other). 
Triploids have to be propagated vegetatively 
because they are sexually sterile. Many banana 
varieties and seedless watermelons are triploids. 
Polyploids occur naturally but can also be 
created by the use of a chemical called colchicine 
that prevents the chromosomes from separating 
during the cell division process. Colchicine has 
been used to create autopolyploids and seedless 
triploids as well as to restore fertility in triploids 
like Triticale (wheat crossed with rye) by 
making it hexaploid (six sets of chromosomes).
PLANT TISSUE CULTURE
Plant tissue culture is a collective name for various 
laboratory techniques used for culturing parts of 
plants under controlled sterile conditions using 
either cells, tissues (pieces of leaves, flowers, or 
roots), or anther, microspore, or meristem  
(undifferentiated cells) from the plant. 
Plant tissue culture is used as a vegetative propa-
gation method for mass production of plantlets 
in many species, especially woody horticultural 
species that are difficult to propagate by grafting. 
It is also a very useful tool for long-term preser-
vation of genetic material from endangered species. 
Plant tissue culture also has important applica-
tions in plant breeding. For example, completely 
homozygous lines can be created by preventing 
In Sweden, all sugar beet varieties produced in breeding 
programmes are hybrids.
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the chromosomes from separating in the first 
cell division in immature pollen (which in a 
diploid only carries one set of chromosomes). 
The resulting plants are referred to as “double 
haploids”. Tissue culture is also used in the 
production of GM plants. 
The theoretical basis of tissue culturing 
is that every intact cell has the potential to 
grow and develop into a complete plant under 
optimal growing conditions, that is, the cells 
are totipotent. Plant tissue culture is also called 
in vitro culture (“in glass” in Latin) because the 
plants are often grown on a solid medium in a 
small glass jar. The growth medium normally 
consists of nutrients including sugars, salts, and 
vitamins that are necessary for the cultures to 
grow, as well as plant hormones that regulate 
growth and development. The medium is 
usually jellified with agar (a polysaccharide/
pectin mixture from red algae) mainly to avoid 
abnormal growth by preventing the cultures 
from taking up too much water. However, there 
are also liquid cultures where plant cells or tissues 
are grown in a nutritional liquid medium in a 
specially designed container called a bioreactor. 
Bioreactors can be used for cultivating plant cells 
or tissues for extraction of important compounds 
with medical value. 
There are several advantages with this 
technique, including disease-free (especially 
virus-free) plant material, mass production of 
high-quality plants within a short time in a 
limited area, year-round production, and no 
need for pesticides.
MOLECULAR SELECTION
If one has knowledge about which alleles (vari-
ants of a gene) result in a specific phenotype, 
which genes affect a trait, or just which regions 
of a plant’s DNA are associated with a trait, the 
best individuals can be chosen without having 
to wait for the plant to fully develop, flower, set 
seed, etc. This saves both time and resources. 
QUANTITATIVE TRAIT LOCI
As described in the section about animal breed-
ing (page 30), “quantitative trait loci” (QTLs) 
are regions of the DNA that have a significant 
effect on a quantitative trait, for example height. 
A single trait is often influenced by several QTLs 
that can be located on different chromosomes. 
QTL analysis has been an effective tool in allow-
ing for the selection of useful genes that govern 
traits such as grain productivity and plant height. 
MARKER-ASSISTED SELECTION 
The majority of the selection markers used in 
plant breeding today are based on DNA, but 
such markers can also be morphological or bio-
chemical markers. As described in the section on 
animals (page 30), the theory behind this meth-
od is that one can use a marker to select for, or 
against, a gene that is associated with a specific 
trait. To find DNA markers, one must compare 
individuals with a high degree of variability in 
the trait of interest. A good marker is so closely 
linked to the gene of interest that the probability 
is very low that the marker and the gene will 
segregate during meiosis. Marker-assisted selec-
tion is an important tool in plant breeding. 
GENOMIC SELECTION 
As described previously, genomic selection is an 
important tool in animal breeding. Now also 
plant breeders are becoming more interested in 
this selection method. Genomic information is 
already available for some plants, and this allows 
for an assessment to be made for many genetic 
markers across the genome. However, the progress 
in acquiring knowledge of the entire genome has 
been slow in most species. One of the main rea-
sons for this is that many crops are polyploids, that 
is, they have more than two sets of chromosomes 
and, therefore, more than two alleles per locus 
(see page 15). Additionally, many plants have 
complex genomes, including repetitive sequences 
and pseudo-genes (genes without function). 
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However, due to decreased costs the genomes of 
many crops like rice, maize, potato, and bread 
wheat have now been sequenced and techniques 
for genomic selection in plant breeding are being 
developed. The procedure, in principal, is the 
same as in livestock, but the genomic complexity 
in terms of polyploidy and the modes of reproduc-
tion differ greatly among plant species. Trees are 
a great example of plants where breeding would 
benefit from genomic selection because their re-
productive period and time until harvest are very 
long. The ability to predict future wood or fruit 
quantity and quality at an early stage of develop-
ment would, therefore, be highly beneficial. Sam-
ples could be collected at an early stage and their 
genotypic data could be compared to older trees 
with known phenotypic measures. The applica-
tion of this technique will not be as easy in crop 
species where reproduction and breeding schemes 
differ among species, and the approaches must 
be adjusted to different breeding populations. 
Genomic selection is still a promising method in 
plant breeding, but it might be that it will only be 
fully employed in the breeding of trees. 
PROTEOMICS AND METABOLOMICS
Proteomics is the study of the protein makeup 
of an organism. Genomics can be compared to 
a cookbook filled with recipes, and proteomics 
can be compared to the wide variety of dishes 
that can be created by following the recipes in 
the book. While genomics to some extent can 
predict the phenotype of an organism, large-
scale measurements of proteins and metabolites 
– proteomics and metabolomics, respectively – 
provide a more accurate view of the true pheno-
type and are easier to interpret. 
Proteins make up the machinery of the cells, 
and they mediate signalling and chemical events 
by catalysing a vast array of chemical reactions. 
Measuring the levels of specific proteins can be 
used to predict the features that will occur in 
different crosses in breeding programmes and 
can be used as an alternative or complement to 
the use of genomic markers. One way to study 
the different proteins in a sample is to first digest 
them with a specific enzyme to obtain peptides 
(small proteins). The peptides in the mixture are 
then separated based on their polarity, and the 
levels of specific peptides are measured. Highly 
reproducible measurements can be achieved with 
a technique called Selected Reaction Monitoring 
that allows hundreds of peptides to be measured 
in a large sample cohorts. Metabolites are small 
molecules such as various types of carbohydrates 
and amino acids in the cells. Those are usually 
separated in the same manner as the proteins but 
the metabolites are identified using, for example, 
mass spectral fingerprint libraries. There are 
still many technical challenges to be overcome 
before complete proteomic and metabolomic 
measurements can be made, but the use of these 
techniques in breeding is promising. 
GENETIC ENGINEERING 
This section describes modifications of plant 
genes using molecular approaches. This includes 
breeding methods in which the expression of a 
target gene is altered or a foreign gene is in-
troduced into the genome of a target crop for 
developing a desirable trait. Depending on which 
technology is used, the product obtained may 
or may not be defined as a genetically modified 
organism (GMO). The technologies that are in 
use in plant breeding today are explained along 
with some of the new methods that are expected 
to have broad applications in crop development in 
the future. For definition of GMO, see page 67. 
GENETIC TRANSFORMATION 
Even though one might change a trait or intro-
duce a new one using the classical techniques 
described previously, the desired results can be 
difficult, and in some cases impossible, to obtain. 
These are cases where genetic transformation 
can prove useful. This technique is particularly 
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advantageous for improving existing varieties that 
have just one or a few flaws or undesirable traits. 
Genetic transformation involves the direct 
introduction of a piece of DNA or a whole gene 
into an organism’s genome in order to express a 
foreign gene or to modify the expression of the 
organism’s own genes. The crops modified using 
this technique are called genetically modified 
(GM) crops. Because the functions of the target 
genes to be modified are usually well charac-
terized, the genetic transformation approach is 
more precise and straightforward compared to 
conventional breeding by crossing or mutation. 
These techniques also eliminate the disadvantage 
of traditional crossing methods in which several 
genes are added along with the gene of interest.
Genetic transformation in plants is normally 
carried out with the help of the soil bacterium 
Agrobacterium tumefaciens. In nature, the bacte- 
rium can infect wounded plants and cause 
tumour (also called crown gall) formation. Most 
bacteria have their DNA in the form of a main 
circular chromosome and several smaller circles 
of DNA called plasmids. A. tumefaciens has a 
tumour-inducing (Ti) plasmid that contains a 
piece of DNA called T-DNA (transfer-DNA). 
T-DNA can be transferred into the plant 
cells and incorporated into the genome of the 
infected plant. The T-DNA carries the genes 
that stimulate the cell division without differen-
tiation that leads to tumour formation.
The part of the plasmid responsible for DNA 
transfer from the plasmid into the genome 
consists of only about 25 base pairs at the 
beginning and end of the DNA sequence to be 
transferred. The sequences in between these 
two bordering sequences can be replaced with 
any other DNA sequence without affecting the 
DNA transfer. The discovery of this natural 
gene transfer that works across species barriers 
has provided a powerful tool for the genetic 
improvement of plant properties. 
Restriction enzymes, which function like 
scissors, can cut DNA into pieces, and ligases, 
which work like glue, allow the cut pieces of 
DNA to be put back together. These enzymes 
are used to remove the genes causing tumours 
from the T-DNA in the isolated plasmid and 
The most common method for the genetic transformation of plants is to make use of Agrobacterium tumefaciens’ ability 
to insert DNA. The bacterium have a plasmid that carries tumor-inducing (Ti) genes that, together with other genes, 
are inserted into the DNA of the infected plant. Those other genes can be deleted and replaced by one or several genes 
chosen by the breeders. 
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Ti-plasmid
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to replace them with the DNA sequence of 
interest. The modified Ti-plasmid, now called 
a recombinant plasmid or a transformation 
vector, is transferred back into A. tumefaciens. 
The bacterium is then propagated and the 
plant is infected. This method can be further 
divided into either tissue culture-based trans-
formation (TCBT) or in planta transformation. 
For TCBT, a piece of plant tissue or organ 
(called an explant) is cultivated in vitro and the 
target gene is introduced into the explant by 
A. tumefaciens. A new and genetically modified 
plant carrying the target gene can then be grown 
from the explant. For in planta transformation, 
open flowers on a living plant are infected with 
A. tumefaciens. The infected plant will then 
produce seeds that can be harvested and sown. 
The individual plants that grow from these seeds 
will carry the new gene or genes into subsequent 
generations. This method tends to work very 
poorly for the majority of plant species and is 
mainly used in model plant species such as thale 
cress (Arabidopsis thaliana). 
A. tumefaciens transformation has been used for 
genetic modification in many plants, especially 
dicotyledonous* species, to improve various 
agronomically important traits such as disease or 
insect resistance. Compared to dicotyledonous 
plants, monocotyledonous species are in general 
less susceptible to Agrobacterium infection. To 
solve this problem, some alternative chemical 
and physical DNA transfer methods have been 
developed. Among these, the most commonly 
used is biolistics using a gene gun or particle 
bombardment. In this method, the target DNA is 
coated on the surface of gold or tungsten particles. 
The micro-particles are then introduced into the 
plant cells or tissues with a propelling force such as 
compressed gas (helium) or electrostatic discharge. 
Note that also some variants of site-directed 
nucleases (SDNs), described in the next section, 
include genetic transformation.
Infected 
 plant cell
The recombinant DNA is introduced into plant 
cells through infection by the bacterium
T-DNA carrying  
new gene within  
plant chromosome
Plant  
with new trait
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Examples of Site Directed Nucleases (SDNs); Zinc Finger Nucleases (ZFNs) and Transcription Activator-Like 
Effector Nucleases (TALENs), which are based on the same principle. A cutting domain is combined with a 
designed binding domain that will determine where the cut will be made. In the first example the protein complex 
can be introduced via DNA, mRNA, or as a pre-made complex. It is only in the third example that introduced 
DNA is incorporated into the genome.
SITE-DIRECTED MUTAGENESIS 
Site-directed mutagenesis methods have been 
developed to overcome the problem of random-
ness that results from mutation breeding as de-
scribed in the previous section. These techniques 
allow particular sequences in a given gene to 
be modified in a specific manner. Site-directed 
mutagenesis can be achieved with different 
techniques including oligonucleotide directed 
mutagenesis (ODM), zinc finger nucleases 
(ZFNs), transcription activator-like effector 
nucleases (TALENs), homing endonucleases 
(HEs), and, very recently, clustered regulatory 
interspaced short palindromic repeats (CRISPR) 
and CRISPR-associated (Cas) systems. The 
ZFNs, TALENs, HEs, and CRISPR/Cas are 
collectively known also site-directed nucleases 
(SDNs).
ZFNs are synthetic restriction endonucleases 
(enzymes that cut DNA strands) consisting of 
a customized DNA binding domain fused to a 
non-specific nuclease domain. The technique 
enables the introduction of a double strand break 
in any DNA sequence, and the cell responds 
by repairing the break resulting in a random 
mutation at the target site. The technique 
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has been used in maize and tobacco, but the 
efficiency of mutagenesis is low in most plant 
species. This introduction of a random mutation 
at a specific site is generally called ZFN-1 or 
SDN-1 according to the specific class of nucleases. 
The ZFN-2 (SDN-2) method works like ZFN-1 
with the difference that a repair template for 
the desired alteration is included. This template 
is used by the target cell’s repair machinery to 
produce a DNA sequence that is modified at 
specific single nucleotides. The ZFN-3 (SDN-3) 
method introduces genetic material at a specific 
site. The difference with this method compared to 
introducing DNA with A. tumefaciens or biolistic 
techniques is that the insertion is directed to a 
specific site in the genome. 
Similar to ZFNs, TALENs also have a 
customized DNA binding domain fused to 
a non-specific nuclease domain. Here the 
DNA binding domain consists of a longer 
modular structure derived from the bacterium 
Xanthomonas. The nuclease domain can cut 
the DNA strand at a single nucleotide and 
each module can be engineered to recognize 
DNA sequences up to 30 base pairs, which 
improves the targeting specificity compared 
to ZFNs. TALENs enable the introduction of 
double strand breaks into virtually any DNA 
sequence with high efficiency in plants, and this 
technique is predicted to have broad applica-
tions in the future. As with ZFNs, TALENs can 
be used either to introduce an error (to knock 
out a target gene) or to introduce a new DNA 
sequence into the target site (that is, to perform 
genetic transformation).
Homing endonucleases (HEs) are naturally 
occurring enzymes that recognize rare 
DNA sequences from 14 to 44 base pairs in 
length. This feature makes them suitable for 
site-directed mutagenesis. Both natural and 
engineered HEs have been used to introduce 
double strand breaks, mainly in mammals. The 
main limitation to the use of HEs is that the 
DNA binding domain is not clearly distinct from 
the nuclease domain, and this complicates the 
engineering procedure.
Similar to ZFNs and TALENs, the CRISPR/
Cas systems also introduce double-strand breaks 
into almost any DNA sequence, but in this 
case specificity is achieved by pre-loading the 
nuclease with a small RNA molecule comple-
mentary to the target DNA.
Common for the ZFNs, TALENs, HEs, and 
CRISPR/Cas systems are that they cause altera-
tions at specific sites in the genome. They can 
be introduced into the plant cells by electropo-
ration (a short burst of high-energy electrical 
discharge) or treatment with polyethylene glycol 
(PEG) that facilitates penetration of the molecule 
through the cell membrane. With this method, 
integration of new DNA into the genome 
is much less frequent than in Agrobacterium 
transformation and in most of the cases only 
a temporary expression of SDNs is achieved. 
In this latter case, no new genes are left in the 
genome but the DNA modifications that the 
SDNs have introduced can be permanent. In 
the case where stable integration of the genes 
coding for SDNs occurs, it is still possible that 
the process of segregation can result in offspring 
that do not carry these new genes. 
Other methods of delivery of SDNs are 
possible, for example, mammalian and insect 
embryos can be injected with mRNA encoding 
for SDNs. Direct delivery of SDN proteins 
would not include transfer of DNA, but such 
techniques will require further development if 
they are to be applied effectively in plants.
In conclusion, site-directed mutagenesis is a 
technique that enables precise modifications of 
DNA sequences. In those cases where genes are 
modified without insertion of any foreign DNA, 
the new genotypes might be classified as non-GM.
The ODM technique involves targeting 
DNA with short sequences carrying the desired 
mutation, usually about 20–30 base pairs. These 
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In oligonucleotide directed mutagenesis (ODM), a short single strand of DNA complementary to the region to be ed-
ited, except for one nucleotide, is introduced into the cell. The cell’s repair system recognizes the mismatch and replaces 
the nucleotide with the complementary one. The added single strand of DNA will then be degraded by the cell. 
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are introduced into the cell through the same 
processes of electroporation or PEG transfor-
mation used for SDN. ODM sequences are 
complementary to a region in the target gene 
and carry a desired modification but do not 
carry any nuclease domains. This technique is 
very simple but the efficiency is extremely low 
and other mutations can occur. The technique 
has been used in maize, rice, tobacco, and 
rapeseed to modify their herbicide tolerance 
traits. A variety of rapeseed developed with this 
technique has been grown in field trials in the 
UK and is regarded as a non-GMO.
MICRO-RNA AND RNA INTERFERENCE
Another expanding research area focuses on 
microRNA (miRNA). These are short RNA 
molecules that are not translated into proteins 
but instead regulate the levels of gene expression 
by interfering with the mRNAs of genes before 
they are translated into proteins. If a miRNA is 
complementary to a part of the mRNA se-
quence, it will pair with the mRNA resulting in 
a double-stranded RNA. This double-stranded 
RNA will be cut into small pieces by a spe-
cific RNA-cleaving enzyme (which normally 
functions in the cell to destroy double-stranded 
viral RNAs). This principle is used in genetic 
engineering for down-regulating the expres-
sion levels of target genes and is called RNA 
interference (RNAi). The miRNA is introduced 
through regular transformation techniques (A. 
tumefaciens or a gene gun). The method has been 
widely used in human disease studies and in 
animal and plant breeding. For instance, this 
technique has been used to increase the level of 
the beneficial plant oil oleic acid in soybeans to 
over 80% of the total oil content.
Designed micro-RNA can be used to change the expression of specific genes. This technique has for example been 
used to raise the levels of oleic acid in soybeans.
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This principle of RNA interference (RNAi) is used for down-regulating the expression levels of target genes by 
preventing mRNA from being translated into a protein. A gene that codes for a RNA strand complementary 
to the gene’s mRNA is transferred into the genome. The two RNA strands pair up to form a double-stranded 
RNA. In plants mRNA normally only exist as single strands and double-stranded RNA is quickly degraded by 
the cellular enzymes that protect the plant against viruses.
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The majority of commercial products based 
on genetic modification – such as medicines, 
detergents, and food additives – come from GM 
microbes, but it has been GM crops, and more 
recently, GM animals that have received the 
most attention.
Large-scale cultivation of GM crops began 
in 1996 in the US. Since then, cultivation of 
such crops has expanded continuously in both 
developed and developing countries. Today, GM 
crops cover an area that represents approximately 
11% of the world’s cultivated area. This dramatic 
expansion makes GM crops one of the most 
rapidly adopted technologies in the history of 
agriculture. The main GM crops cultivated today 
belong to what is often referred to as the “first 
generation” of GM crops that were designed to 
lower the farmer’s production costs by introducing 
traits such as herbicide tolerance (HT) and insect 
resistance (IR). The “second generation” of GM 
crops have been modified to change the product 
quality, including increased nutritional value, 
healthier oils, and the removal of allergens. The 
“third generation” of GM crops produce industrial 
products and pharmaceuticals such as vaccines.
GM farm animals and fish for food production 
include a number of species engineered with the 
aim of improving economically important traits 
such as growth rate, meat quality, wool growth, 
feed conversion, milk composition, mastitis 
resistance, lactation, and survival. An area that 
will likely become important in the near future 
is the creation of “environmentally friendly” 
GM farm animals that will be developed to 
reduce negative impacts of animal production. 
The development of GM farm animals for food 
production lags behind more economically 
profitable medical applications. For example, 
GM animals are used for the production of 
pharmaceuticals, known as “gene pharming”, 
and are potential sources for the production 
of organs and tissue for human transplantation 
(this process is known as xenotransplantation). 
Proteins and antibiotics are produced by GM 
farm animals via their mammary glands. Several 
proteins for human use have already been 
commercialized, or are close to commerciali-
zation, for treating coronary and lung problems 
and for functioning as blood substitutes and 
anticoagulants. GM animals are also used in 
research as models for human diseases. 
Products developed  
through genetic modification 
Areas cultivated with the 4 major GM and conventional crops 
globally in 2013 (million hectares) (based on James 2013)
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GENETICALLY MODIFIED CROPS
Although there are a wide range of plants with 
GM traits approved for commercial cropping 
(see page 52-53) it is foremost four crops that 
feature the two traits of herbicide tolerance (HT) 
or insect resistant (IR), or a combination of the 
two (stacked traits) that are widely grown. Most 
of the HT crops developed through genetic 
modification are engineered to tolerate the 
herbicides glyphosate or glufosinate, and the 
IR crops carry genes from different strains of 
the soil bacterium Bacillus thuringiensis (Bt). The 
different Bt proteins have very specific toxicities 
and target certain insect orders. The four major 
GM crops grown commercially today are HT 
soybean, Bt and HT maize, Bt cotton, and HT 
rapeseed. However, as shown in the table on 
page 52-53 there are numerous GM plants with 
a variety of modified or introduced traits. 
During the period of 1996 to 2013, farmers in 
29 countries planted an accumulated 1.6 billion 
hectares of various GM crops. In the US, the 
adoption of GM soy has reached 93% of the 
total soy area. India is the leading country in the 
world in terms of area dedicated to Bt cotton, 
which constitutes 95% of the total cotton culti-
vation area and is farmed mainly by small-scale 
farmers. India is followed by China and the US 
in cultivation of Bt cotton. 
Bt maize was the first GM crop to be approved 
for commercial cultivation in the EU (in Spain 
in 1997). As of 2013, only two GM crops have 
been approved in the EU, including several 
cultivars of the MON810 Bt maize, and the 
Amflora* potato. Five EU countries (Spain, 
Portugal, Czech Republic, Slovakia, and 
Romania) grew a total of 148,000 hectares of 
GM crops commercially in 2013. 
In 2010, Sweden became the first Scandi-
navian country to commercially grow the 
Amflora potato. This potato has a modified 
starch composition that makes it produce 
mainly amylopectin starch that is used for 
high-quality glazed paper and adhesives, and in 
the textile industry. It reduces production costs 
and optimizes processing thus using less water, 
energy, and chemicals. The potato was also 
grown in Germany and Czech Republic.* 
TRAITS
CROPS
GM crops and traits commercially grown globally  
in 2013, based on area. (Based on James 2013)
Rapeseed
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GENETICALLY  
MODIFIED MICROBES 
Humans have made use of the fermentation pro-
cess of bacteria and yeasts for thousands of years. 
However, it was not until the 19th century that 
these processes were understood to result from 
the activity of these microorganisms. At that 
time, the development of techniques for growing 
pure cultures and improving yeast strains began. 
A major advance in large-scale production was 
the production of penicillin during World War 
II. GM microbes are now used in mineral recov-
ery, medicine, environmental protection, food 
production, and agriculture.
The first organism to be genetically modified 
was a bacterium. As mentioned previously, 
bacteria have DNA in additional small rings of 
DNA called plasmids. These plasmids can be 
isolated from the bacteria and their genes can 
be replaced by genes coding for the protein 
of interest. The modified plasmids are put 
back into the bacterium, and the bacterium 
will produce the protein (see figure on page 
11). As the bacteria culture grows, so will the 
production of the protein. The development of 
bioreactors and the ability to specifically tailor 
microorganisms have enabled the large-scale 
production of complex natural compounds. 
Before such methods were developed, the 
only way to provide insulin to people with 
diabetes was to produce it in farm animals such 
as cows and pigs. The process of collecting 
the pancreases of the animals was tedious and 
costly, and even though the insulin produced 
in this manner is similar to human insulin, it 
is not identical and this has caused problems 
for many patients. Today, genetically modified 
Escherichia coli bacteria carrying the human 
insulin gene provide almost all the insulin 
used by human patients. There are many other 
examples of medical proteins that are manufac-
tured by GM bacteria.
Insulin was one of the first commercial products to be produced with GM microorganisms.
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Antibiotics Ampicillin
Benzylpenicillin
Cefoxitin
Ceftriaxone
Cephalexin
Erythromycin A
Methicillin
Streptomycin sulphate
Tetracycline HCl
Vancomycin HCl
…and many more
Ascorbic acid (Vitamin C)
Biopolymers Melanins: Animal adhesive proteins  
(from the blue mussel) 
Rubber (originally from the plant Hevea brasiliensis)
Biodegradable plastics (polyhydroxyalkanoates)
Blood-clotting protein Blood clotting factor VIII. For patients with forms 
of the bleeding disorder haemophilia. Before 
the protein was obtained by processing large 
quantities of human blood from multiple donors 
(risk of transmission of infectious diseases)
Carbohydrate processing enzymes Convert starch to glucose, or glucose to fructose
Detergents Protein-degrading enzymes
Enzyme for cheese production Chymosin, first GM food additive used commer-
cially. Traditionally, the enzyme is obtained from 
rennet, from the fourth stomach of milk-fed calves
Hepatitis B vaccine Hepatitis B virus, unlike other common viruses 
such as polio virus, cannot be grown in vitro
Human growth hormone (HGH) Somatotropin. Before recombinant HGH became 
available, HGH for therapeutic use was obtained 
from pituitary glands of slaughtered animals
Insulin For patients with diabetes
Amino acids for:
Production of flavour enhancers 
Therapy for liver diseases
Bread production, therapy for 
bronchitis, antioxidant
Cosmetics 
Intravenous solutions
Aspartic acid
Arginine
Cysteine 
Serine
Valine
…and many more
Vitamin B12
Examples of products from genetically modified microorganisms.
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GENETICALLY MODIFIED ANIMALS 
Canada is currently the only country that has 
approved a GM animal for food - the eggs from 
a transgenic salmon (AquAdvantage®). The 
fish it self (described below) is expected to be 
approved by the US Food and Drug Administra-
tion within the near future. 
Fish: The main interest regarding GM fish 
has been in general growth enhancement with 
a focus on species already commercially grown 
via aquaculture, such as salmon fishes, carp, and 
tilapia. The AquAdvantage® salmon is a GM 
Atlantic salmon that carries a growth hormone 
gene from the Chinook salmon that provides 
the fish with the potential to grow 5 to 10 times 
faster during an early stage of life and thus 
reach market size (4–6 kg) one year earlier than 
non-GM salmon. Another recent strategy to 
directly increase fish meat production is aimed 
at “double muscling” in rainbow trout. These 
fish have been genetically modified to improve 
the efficiency with which they convert food into 
muscle mass. More recently, genetic modifi-
cation in fish has been used to improve disease 
resistance and survival and this has increased the 
areas in which fish can be cultivated. 
Pigs: A number of genes have been transferred 
to pigs to improve their growth, health, and 
reproduction and to alter their meat compo-
sition. Such modifications could lead to pig 
production that is better for the environment 
or that provides healthier meat for consumers. 
Another example is improved milk quality in 
sows that enhances piglet survival and early 
growth. The insertion of growth hormone 
genes has resulted in pigs with increased growth 
rates, a larger ham, and a higher percentage 
of lean meat. Meat quality has been improved 
by changing the amounts of fatty acids such 
as omega-3. Improved disease resistance, such 
The AquAdvantage® Salmon (background) is a GM Atlantic salmon that carries a growth hormone gene from 
the Chinook salmon that makes it grow faster during an early stage of life and reach market size one year earlier 
than non-GM Atlantic salmon of the same age ( foreground).
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as resistance to swine influenza, is another 
motivation for producing GM pigs.
“Environmentally friendly” GM pigs have 
been developed with the aim of reducing the 
environmental impact of pig production. An 
example of this is the Enviropig project in 
which GM pigs produce an enzyme (phytase) in 
their saliva. The gene coding for phytase comes 
from a bacterium and the enzyme enables the 
pig to utilize all of the phosphate in their feed. 
Thus, the faeces of Enviropigs contain 60% less 
phosphate than conventional pigs. Phosphorus 
leakage from farmland is a huge environmental 
problem because too much phosphate leaching 
into lakes and seawater results in massive algae 
growth. In addition, the availability of high-
quality phosphorus is limited thus feed costs for 
the Enviropigs are reduced because they do not 
require a phosphorus supplement in their diet.
Cattle: GM cattle are used in the production 
of pharmaceuticals in milk and as models 
for human diseases. However, the interest in 
GM cattle for food production is increasing. 
Particular attention has been devoted to milk 
quality, udder health, and disease resistance. 
Udder problems, often mastitis, are one of 
the main reasons for antibiotic treatments and 
the early culling of dairy cows. The disease 
is painful for the cows and it costs the world 
dairy industry billions of euros every year. GM 
cows that secrete an antimicrobial substance 
(lysostaphin) in their milk have shown enhanced 
resistance to mastitis and improved udder 
health. Other examples are cows that produce 
more beta- and kappa-casein in their milk, 
which improves the quality of the milk and the 
transformation process from milk to cheese. In 
addition, GM cows with altered ratios of fatty 
acids in their milk could have a positive effect on 
human health.
Goats: In goats, particular attention has been 
given to udder health and milk quality. The 
human enzyme lysozyme that is produced in 
the milk of GM goats has positive effects on 
the development of lactic acid bacteria in the 
milk and this leads to improved udder health, 
increased food safety and consumer health, and 
to improvements in the cheese-making process. 
GM goats expressing another enzyme (stearoyl 
desaturase) produce milk with higher propor-
tions of monounsaturated fatty acids, which 
might be beneficial for human cardiovascular 
health. 
Sheep: GM sheep have been created to 
improve wool production and disease resistance, 
and the transfer of a gene producing an insulin-
like growth factor has resulted in increased 
fleece weight. Another GM sheep has been 
developed to resist viruses that cause pneumonia 
and arthritis in sheep. Also, sheep resistant to 
“mad cow disease” (bovine spongiform enceph-
alopathy - BSE), a lethal disease in humans and 
animals, have been developed through genetic 
modification.
Chickens: Chickens have been genetically 
modified mainly to increase resistance to 
diseases, increase feed conversion efficiency, 
and increase growth rate, although the latter 
has been met with little success. One example is 
the chicken resistant to avian influenza (caused 
by the H5N1 virus). This virus can cause both 
economic and health problems in animals and 
humans and there is the risk of development of 
new pandemic strains of the virus. 
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Ethics of breeding 
Breeding aims to refine plants, animals, or 
other organisms for particular purposes through 
a process of selection. This process sometimes 
raises ethical issues, such as when questions of 
animal welfare or environmental consequences 
are at stake or when traditional animal breeds 
or plant varieties with cultural significance are 
no longer available. Purposeful changes of genes 
have also been criticized with arguments that 
refer to religious or ethical bounds on what 
mankind is entitled to do with nature.
ETHICS IN ANIMAL BREEDING
The breeding of animals dates back to the first 
attempts to domesticate them and make them 
useful for human purposes. This process has gen-
erally led to changes of some animal behaviours 
and has produced animals that are less frightened 
by humans, less active, and have higher social 
tolerance. It has also produced animals with 
higher reproductivity or changes in phenotype 
such as body size and fur colour. Dogs are not 
only one of the first species to be bred, but are 
also the most clear example of large phenotypic 
change; from a wolf to a Chihuahua. Breeding 
of companion dogs originally sought to achieve 
different capacities such as hunting, herding, and 
guarding and this has resulted in today’s large 
variety of breeds. However, these dogs are sel-
dom used for their original purposes today.
In livestock, on the other hand, increased 
production has been the single, overarching aim 
that has influenced most breeding programmes. 
This includes rapid growth in chickens, high 
milk yield in dairy cows, and a high number 
of offspring in pigs. This process has occurred 
in parallel to industrialization after World War 
II, and it has often been described as a civilisa-
tion’s victory over poverty and malnutrition. In 
many industrialised countries, having meat on 
the table is no longer seen as a luxury. However, 
the increased production of animals for meat 
can also be seen as a threat to civilization. For 
example, the global spread of diseases such 
as BSE and N5H1, the increase in antibiotic 
resistant bacteria, climate change, and negative 
environmental impact are related to efforts to 
reduce production costs, increased specialisation 
of production branches and internationalisation 
of animal production and consumption. In 
any judgment of today’s industrialized animal 
husbandry, both sides of the debate need to be 
taken into account. Important questions that 
need to be addressed include what the role of 
animal breeding is in these developments, what 
role it will play in the future, and how breeding 
programmes can contribute to reduced negative 
environmental impacts. The breeding of farm 
animals, therefore, is not an ethically neutral 
undertaking but rather builds on ethical values 
concerning what has been good so far, what needs 
to be improved, and how future global challenges 
are best met. These issues consider the overall aim 
of farm animal breeding and are at a higher level 
than the narrower choices that are involved in 
defining the goals of breeding programmes.
In all farm animal breeding programmes, 
the primary question concerning the goal of 
the programme is crucial along with why such 
a goal is important. However, ethical aspects 
of animal breeding concern all steps of the 
process (see figure on page 24) including the 
choice of methods, techniques, and variables for 
measurements, the choice of criteria for, genetic 
evaluation, and an evaluation of the estimated 
genetic gain. As described on page 21, these 
steps all contain elements of choices made by 
the breeders and are thus dependent on their 
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evaluation of the offspring – “did we get what 
we wanted?” If not, was this due to limited 
measurements of the genetic traits or to the use 
of the wrong methods? How should one decide 
when a limit is reached and when should one 
re-evaluate the breeding goal? These issues are 
of ethical relevance because sentient animals are 
used and there is a risk of causing them suffering 
or pain due to certain methods such as; hormone 
treatments in egg donors and surrogate mothers, 
artificial insemination, and welfare issues related 
to male animals that are often kept apart from 
other animals. If the evaluation of a goal is not 
properly undertaken, animals might be used 
unnecessarily or the use of a better treatment 
might be delayed. 
In interdisciplinary research that combines 
breeding, animal welfare studies, and animal 
ethics, another core question is whether animals 
should be bred for behavioral changes that 
will allow the animals to better cope with the 
environment or if the environment should be 
changed to better suit the animal’s behavioural 
needs and welfare. So far it has been primarily 
argued that the appropriate solution is to 
create husbandry systems that are suitable for 
the animals, rather than breeding for animals 
that are less frightened or susceptible to stress, 
because low reactions to stress do not neces-
sarily imply good animal welfare. Additional 
ethical aspects of breeding are relevant at the 
farm level, that is, in the daily use of the breeds. 
In general, animal health is considered to be 
important as long as it has a concrete economic 
value, but broader aspects of animal welfare are 
also relevant. As mentioned previously, mastitis 
The average dairy cow in Sweden produces over 8000 kg of milk per year. Are there any ethical aspects on in-
creasing the production even more?
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is a common welfare problem on dairy farms 
and any solution to this problem would be 
welcomed. On the other hand, mastitis is related 
to production levels and to a general increase 
in yield, even if not each individual cow have 
an increased production. Another example of 
an ethical dilemma is the litter size of sows that 
increasingly give birth to more piglets than they 
have teats. A recent study has shown that dairy 
and pig farmers would be likely to accept lower 
milk and litter size if this increased animal health 
and thus lowered the disease and mortality risk 
and, albeit indirectly, reduced costs. 
From an ethical point of view, both the aim 
of breeding and the selection of traits have to 
be considered. As to the first, what is the role of 
these high producing cows and sows in a global 
context? For example, what are the conse-
quences of increased production per animal in 
terms of issues like food security, farmer income, 
global disease control, and animal welfare? As 
to the second, what traits are necessary for a 
robust animal and how should such robustness 
be defined? Even if it might be economically 
sustainable to cull a high-producing cow at an 
age of four or five due to mastitis rather than 
to use a less productive but healthier breed, is 
such activity also environmentally sustainable? 
And what are the social aspects; what do farmers 
think and what do consumers know? From an 
ethical point of view, any current practice can be 
scrutinized and discussed with the aim of finding 
the most solid arguments for each position.
Another ethical issue is whether animals have 
intrinsic value. Criticism of the genetic modifi-
cation of farm animals has often been related to 
their intrinsic value, whereas genetic modifi-
cation of mice for medical purposes has become 
a self-evident necessity. Thus, other aspects such 
as the role of the animal, our relation to it, or 
simply tradition strongly influences what we 
think is acceptable to do with an animal. Also, 
given the different methods for changing the 
genetic makeup of an animal (as described on 
pages 25-31) it might be difficult to see a clear 
distinction between conventional breeding and 
genetic modification. Is the most relevant ethical 
aspect in the choice of method, in the method 
itself, or in the consequences of using a certain 
method? There are a number of ethical issues 
to be considered regarding the importance of 
the methods, and these will be shown in the 
following section about plant breeding. These 
issues also concern animal breeding.
ETHICS IN PLANT BREEDING
The breeding of plants has rarely been seen 
as involving controversial ethical issues. The 
genetic modification of plants, however, is often 
thought to involve such issues. It is a common 
belief that genetic modification is wrong, but 
what might such a claim amount to and what 
might it imply?
Some people have objections to the 
technology as such – that there is something 
inherently wrong with genetic modification 
that sets it apart qualitatively from changing 
a genome through traditional means such as 
selective reproduction. One such argument 
is that genetic modification is unnatural 
and, therefore, immoral or at least morally 
problematic. A representative of this position 
is the Prince of Wales, who in his commentary 
on the 2000 Reith Lectures on BBC Radio 4 
argued that “above all, we should show greater 
respect for the genius of Nature’s designs – 
rigorously tested and refined over millions of 
years. This means being careful to use science to 
understand how Nature works – not to change 
what Nature is, as we do when genetic manipulation 
seeks to transform the process of biological evolution 
into something altogether different” (emphasis 
added). This is a strong claim, and even if many 
people share the idea of genetic modification 
as “unnatural”, it appears to be less of a moral 
problem in medical applications such as when 
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GM microorganisms produce insulin for treating 
diabetes.
The opposition might not be so much against 
GM technology as such, but more against 
different applications of it. This means that even 
people who do not have an objection in principle 
to the technology still can be critical to its use 
in agriculture in general or in food production 
in particular. This way of arguing is an appeal 
to the consequences of the technology and to its 
applications. Some people emphasize the risks 
and uncertainties of this new technology and 
argue either that there are risks to human health 
or the environment or that there might be such 
risks and that for this reason some version of the 
precautionary principle should be applied.
A large part of the discussion around the ethics 
of GM crops has been focused on issues of risks 
to human health and the environment. Consid-
erable efforts have been made by GM proponents 
to argue that the crops themselves are not riskier 
per se than any other type of agricultural plant 
by citing extensive evidence from risk assess-
ments of GM crops. Opponents of GM crops are 
skeptical to such arguments. However, this focus 
on risks might be partially misleading. Many 
people who are critical of GM crops are critical 
not because they think they are dangerous, 
but for other reasons. First, many GM critics 
emphasize uncertainty or ignorance. While 
risk connotes quantifiability and manageability, 
uncertainty and ignorance mean that the degree 
of risk from a particular activity is not known, 
or at least is insufficiently known. This can be 
compared to a game of dice. Imagine that there 
are two dices in a cup, and that you are asked 
to place a bet on one of the dices showing a six. 
The likelihood of this happening can be easily 
calculated. But imagine that you are offered the 
same bet, but without knowing how many dices 
are in the cup (if any at all). The introduction 
of GM crops has been likened the second case 
where it has been argued that potential surprises 
are lurking. Perhaps there is a mouse in the cup 
that will bite you! Hence the reference to the 
precautionary principle. Secondly, GM crops 
are seen as perpetuating a particular economic, 
social, and cultural world order that includes 
large-scale industrial agriculture. Thus, criticism 
of GM crops might not be directed towards the 
technology as such but against its social conse-
quences. Genetic modification, it is argued, 
is another way of transferring power from 
consumers and farmers to a small number of 
multinational corporations, from the poor to the 
rich, and from the developing countries to the 
developed.
Another reason to look beyond the risk 
discourse is that one critique of GM crops 
has nothing to do with risks but rather with a 
perceived absence of benefits to end users and 
society. First-generation GM crops mainly have 
agronomic traits (herbicide tolerance or pest 
resistance) that are useful to the grower but 
which make no difference in terms of the quality 
of the end product. Chocolate made from GM 
soy and sugarbeet does not taste better than 
non-GM chocolate, so there appears to be no 
inherent reason for the consumer to buy it. 
Whether these arguments are reasonable or 
not can, of course, be debated, and it is quite 
conceivable that some of them might lose their 
intensity as the technology and regulatory 
systems develop. If, for instance, GM crops 
with perceivable consumer benefits – better 
tasting or healthier products – become available, 
the argument based on a lack of such benefits 
would no longer be valid. In addition, political 
reforms might loosen the connection between 
the technology and particular corporations. Such 
reform may include changed patent rules or 
increased public involvement in the development 
of new crops, thus diminishing the dominance 
of the corporations.
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Rules, regulations, and policies 
for breeding and biotechnology 
EU Directive 2001/18/EC on the  
deliberate release into the environment of 
GMOs defines a GMO as “an organism, 
with the exception of human beings, in 
which the genetic material has been altered 
in a way that does not occur naturally by 
mating and/or natural recombination”.
The general regulatory framework of 
GMOs within the EU constitutes part of the 
doctrine of the Food Law established by Regula-
tion 178/2002 of the Council and the European 
Parliament. However, the first rules on GM 
products already appeared in Council Directive 
90/220/EEC of 23 April 1990 on the deliberate 
release into the environment of GMOs. This was 
followed by the Commission Regulation (EC) 
No 258/97 of the European Parliament and of 
the Council on 27 January 1997 concerning 
novel foods and novel food ingredients. 
A series of critical food-related events in the 
1990s (not related to GMO products), including 
BSE, E. coli, and Salmonella outbreaks and the 
discovery of dioxin residues in foodstuffs 
resulted in a number of important changes 
within the EU concerning the regulation of 
food, and these regulations still apply today. 
One of the changes in the 1990s was the move 
from “vertical harmonisation” or “industry 
specific” regulations to “horizontal harmoni-
sation”. Vertical harmonisation means that the 
rules apply to a specific food at all production 
levels. The introduction of “horizontal harmo-
nisation” legislation refers to regulations for the 
entire food chain and all of the food and feed 
products or groups of products across sectors 
simultaneously. A number of factors shaped the 
development of the EU regulatory framework 
concerning GMOs, and these involved a great 
deal of politics at the national, transnational, and 
inter-institutional levels. Moreover, a lack of 
confidence in food regulators following the BSE 
outbreak and other crises was combined with 
cultural and traditional differences, dissemi-
nation of information through the media, and 
political activism by a number of groups.
These crises showed that the member states 
could not deal with the problems separately and 
that the EU lacked the tools and mechanisms to 
respond to such crises. At the same time, certain 
parts of the industry and various affected groups 
such as farmers, consumers, and environmen-
talists became active. These groups stressed 
the need for an approach to understanding and 
designing food regulatory systems that are not 
tied to economic markets but instead take the 
consumers’ interests into account. These efforts 
affected the public discourse and shaped the new 
rules. Although GMOs were initially considered 
to be important innovations that could boost 
growth and expand the industry, the crises 
within the food production systems combined 
with the above factors led to the introduction 
of a number of strict regulations and the estab-
lishment of the European Food Safety Authority 
(EFSA). The EFSA, located in Parma, Italy, 
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Current EU legislations on GMOs.
is responsible for risk assessment and risk 
communication on scientific issues while risk 
management remains under the auspices of 
the Commission, specifically the Directorate 
General for Health and Consumers (DG Sanco). 
The GMO rules are decided by the Ordinary 
Legislative Procedure after the Lisbon Treaty 
where both the European Parliament and the 
Council co-decide. 
Several regulatory frameworks govern the de-
velopment and use of GMOs, and the purpose of 
these legislations is to avoid negative effects on 
animals, human health, and the environment. 
Therefore, all GMOs go through a case-by-case 
risk evaluation. Within the EU, the legisla-
tion is founded on common directives that are 
implemented into the national legislation of 
each member state. Hence, based on the com-
EUROPEAN UNION
Directive 2001/18/EC on the deliberate release into the environment of GMOs
Regulation (EC) 178/2002 laying down the general principles and requirements of food law, 
establishing the EFSA, and laying down procedures in matters of food safety
Regulation (EC) 1829/2003 concerning GM food and feed
Regulation (EC) 1830/2003 concerning the traceability and labelling of GMOs and the 
traceability of food and feed products produced from GMOs 
Regulation (EC) No 1946/2003 concerning the cross-border movements of GMOs and 
transposing the Cartagena Protocol on Biosafety into EU law
Regulation (EC) 65/2004 establishing a system for the development and assignment of 
unique identifiers for GMOs
Regulation (EC) 641/2004 regulating the application for the authorisation of new GM food 
and feed, the notification of existing products, and the adventitious or technically unavoidable 
presence of GM material that has benefited from a favourable risk evaluation
Directive 2009/41/EC concerning contained use of GM microorganisms
§
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mon EU directives every member state decides 
on national laws that regulate both the develop-
ment and use of GMOs. In Sweden, for example, 
ten different authorities have responsibilities 
in relation to regulatory decisions concerning 
GMOs: the Swedish Board of Agriculture, the 
Swedish Forest Agency, the Swedish Chemicals 
Agency, the Swedish Civil Contingency Agency, 
the Swedish National Environmental Protection 
Agency, the National Food Administration, the 
Swedish Gene Technology Advisory Board, the 
Medical Products Agency, the Swedish Agency 
for Marine and Water Management, and the 
Swedish Work Environment Authority. 
Depending on the usage and the type of 
organism, one or more of the different govern-
mental agencies are responsible for the evalu-
ation and risk assessment of any particular 
GMO. The rules governing GMOs also make 
a distinction between contained use, deliberate 
release, and commercial usage.
CONTAINED USE
Contained use relates to the use of GMOs under 
conditions where contact between the GMOs 
and the surrounding environment and the public 
are restricted. The use of GMOs in approved 
laboratories and greenhouses are examples of 
contained usage and can involve GM animals, 
plants, and microorganisms in research labora-
tories as well as GM microorganisms used for 
enzyme or pharmaceutical protein production. 
In Sweden, contained use of GMOs is regulated 
by the Ordinance on Contained Use of Geneti-
cally Modified Organisms (SFS 2000:271). The 
Swedish Work Environment Authority is the 
competent authority in the case of GM micro-
organisms and cell cultures of higher organisms. 
Aquatic GM organisms are governed by the 
Swedish Agency for Marine and Water Man-
agement. The Swedish Board of Agriculture 
governs contained usage of all other GMOs 
including terrestrial plants and animals.
DELIBERATE RELEASE
The Swedish Environmental Code defines 
“deliberate release” as any intentional introduc-
tion of GMOs into the environment without 
containment. Examples are field trials with GM 
plants, clinical trials with GM microorganisms, 
and farm-based trials with GM animals. A trial 
of any GMO must comply with the require-
ments laid down in part B of Directive 2001/18/
EC of the European legislation, and such trials 
require a permit from the relevant national com-
petent authorities. In Sweden, this is regulated 
by the regulation on Deliberate Release of Ge-
netically Modified Organisms (SFS 2002:1086). 
In the case of field trials of GM animals and 
GM plants, permits are granted by the Swedish 
Board of Agriculture or by the Swedish Forest 
Agency in the case of trees for wood production. 
Because field trials with GM plants occur 
outdoors, extra precautions such as fences, 
insects nets, seed traps, and minimum cultivation 
distances to related crops and beehives have to 
be implemented to limit the risk of dispersal of 
GMOs into the surrounding environment. In 
the case of animal trials, all precautions must be 
taken to avoid the escape of GM animals and the 
mating of GM animals with wild animals.
New technologies – GMO or not?
In recent years a number of new technologies 
have emerged (see page 39-47). In some 
cases it is unclear if the resulting organism 
is a GMO or not. This is currently being 
investigated in the EU. 
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COMMERCIAL USAGE
Commercial usage of GMOs is referred to in 
the legislation as “placing on the market” and 
includes both supplying and making a product 
available to third parties by, for example, selling 
it. Approval for placing a GMO on the market 
can include one or several possible uses such as 
cultivation, import, processing of living GMOs, 
or the use of GMOs as ingredients in human 
food and animal feed. Decisions on placing 
GMOs on the market are taken collectively by 
the EU member states. There are two ways to 
apply for placing a GMO on the market in the 
EU. One can follow either Directive 2001/18/
EC, which regulates both deliberate release, 
field trials and commercial cultivation, within 
the EU and the importation of a GMO from a 
country outside of the EU, or Regulation (EC) 
no. 1829/2003 that regulates the commercial 
cultivation, importation, processing, and use 
of GM food and feed. As of today, the majority 
of the applications have been filed according to 
Regulation (EC) no. 1829/2003 (see the flow-
chart of the approval process).
An application for placing a GMO on the 
market can be submitted to a competent 
authority in any EU member state. The compe- 
tent authority, in turn, sends the application 
to the EFSA. The EFSA GMO panel conducts 
a scientific risk assessment of the GMO with 
respect to potential hazards to animal or 
human health and to the environment. The 
risk assessment is based on the available scien-
tific literature and documentation handed in by 
the applicant that has to follow internationally 
agreed guidelines according to the CODEX 
Alimentarius*. Based on the risk assessment, the 
GMO panel issues a scientific opinion to the 
European Commission. National authorities 
are invited to comment on the application. The 
decision to approve the application is taken by 
the Standing Committee on the Food Chain 
and Animal Health if a qualified majority vote 
(QMV) can be reached or, if a qualified majority 
One of the unique characteristics of the 
EU is that it incorporates different forms 
of cooperation among the member states. 
Supranational cooperation denotes that the 
member states move beyond the national 
boundaries of interests, and through the 
involvement of the EU institutions reach 
decisions that have a direct effect on the 
member states, based on the provision that 
are set out by the EU Treaties (agreement 
under international law). Intergovernmental 
cooperation is based on the traditional 
international cooperation among states. 
The decisions based on such cooperation 
are binding only for the states involved in 
the process and the EU institutions play a 
facilitating role.
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The decision making process for the authorisation of GMO in the EU according to Regulation (EC) no 1829/2003. 
Applicant
National 
Competent 
Authority
EU 
Commission 
Appeal 
Committee  
(MS)
European Food Safety 
Authority 
(EFSA) GMO Panel
Standing Committee  
on the Food Chain and Animal 
Health (MS)
PHASE 2
PHASE 4 (three scenarios)
PHASE 3
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cannot be reached in the Standing Regulatory 
Committee (SRC), by the Appeal Committee. 
Decisions of approvals are valid throughout the 
European Union. Applications filed according 
to Directive 2001/18/EC (deliberate release 
into the environment) follow a similar route; 
the SRC and the Commission need to consult 
the national competent authorities for the 
environmental impact assessment and have 
three months to reply after the request has been 
made.
Currently, no GM mammals, fish, or insects 
are on the EU market. The EFSA, in coordi-
nation with the European Commission, is 
currently developing environmental risk 
assessment (ERA) guidelines with the aim 
of assessing the possible direct, indirect, 
immediate, or delayed risks to human health 
and the environment by such organisms as well 
as related issues concerning animal health and 
welfare. This will support possible future appli-
cants in submitting their applications for GM 
mammals, fish, insects, and derived products 
for entry into the European market. The 
European member states are revising the ERA 
guidelines and the DG Sanco, in coordination 
with the European Commission, is preparing a 
proposal for new European legislation on GM 
animals, fish, and insects. The ERA guidelines 
will be incorporated into the new EU law, 
and the EU Regulation will be presented and 
discussed by the European Parliament at the 
end of 2014. After approval, member countries 
will incorporate the EU Regulation into their 
national laws. 
LABELLING AND TRACEABILITY
The labelling and traceability of GM food and 
feed are regulated through EU Regulation 
1830/2003. Food or feed that contain, consist 
of, or are produced from GM ingredients have 
to have “genetically modified” or “produced 
from genetically modified x” clearly visible on 
the label* to ensure traceability and freedom of 
choice for the consumers. Also, processed food 
and feed that do not have detectable levels of 
DNA or proteins but that are made from GMOs, 
such as refined sugar and rapeseed oil, have to 
be labelled. Because large parts of the world’s 
production of staple foods such as maize, soy, 
rice, and rapeseed are currently derived from 
GM varieties, involuntary or technical inter-
mixing of GMOs in conventionally produced 
food and feed is sometimes difficult to avoid. 
GM varieties that have been approved within 
the European approval system and do not pose 
any known hazard to animal or human health 
or the environment are allowed to occur up to 
a limit of 0.9 % of that particular species in a 
product, without GMO labelling. Intermixing 
of un approved GMOs is in general not allowed 
in the EU although intermixing up to 0.1% in 
feed is accepted under certain circumstances. See 
Regulation EU No. 619/2011.
Vitamins and enzymes produced from GMOs 
do not require labelling nor do textiles produced 
from GM cotton or oils from GM plants that 
are used for technical or cosmetic purposes such 
as skin care products. Meat, eggs, and milk 
produced from animals that have been fed GM 
feed do not require labelling because the animals 
themselves are not GMOs. In principal, the 
legislation stipulates that food and feed should 
be labelled with what ingredients the food does 
contain rather than what it does not contain. 
Hence, labelling foods as “GM-free”, which 
is commonly found in countries outside of 
the EU, is not supported by the current legis-
lation, although this is interpreted differently in 
different EU member states.
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The demand for traceability stipulates that a 
GMO or a product that contains GM ingredi-
ents or is made out of a GMO (except enzymes 
and vitamins made from GM microorganisms) 
should be followed by documentation that al-
lows traceability through all stages of its produc-
tion and placement on the market.
COEXISTENCE
Because products that contain GMOs have to be 
labelled, involuntary intermixing between con-
ventionally produced products and GM products 
poses an economic risk to the farmers. Farm-
ers using conventionally bred varieties might 
have to label their products if they contain over 
0.9% of a GM crop, and the farmers growing 
GM crops might face liability charges. Coexist-
ence is not regulated at the EU level. However, 
to minimize the risk of intermixing between 
GM varieties and conventionally bred crops, 
Swedish authorities have developed a regulatory 
framework for the cultivation of GM crops. The 
intention with the rules is to reduce intermix-
ing to a level below the threshold of 0.9%. The 
requirements include cultivation distances to 
neighbouring crops (which have been imple-
mented for maize and potatoes), the duty to 
inform local authorities and neighbouring farm-
ers about the cultivation of GM crops, and the 
cleaning of equipment used for GM crops.
Variety testing and  
plant breeders’ rights
In Sweden, and many other countries, all 
developed crop varieties are protected 
by plantbreeders’ rights according to the 
International Union for the Protection of 
New Varieties of Plants (UPOV). (In the US, 
certain crops are protected by patents.) 
This means that you need the rightholders’ 
permission to propagate, promote, and sell 
the protected variety. The exception is the 
production of seeds from some crops for 
use on one’s own farm (this does not apply 
to hybrids), but one still needs to pay some 
of the plant breeder’s fee if the area of the 
farm exceeds a certain size. 
For a variety to be protected (listed) in 
Sweden, it needs to be approved by the 
Board of Agriculture. The variety needs 
to be distinguishable from other varieties, 
uniform, and stable, that is, it does not 
change when it is propagated. Most crops 
also need to have a satisfying Value for 
Cultivation and Use (VCU). Varieties listed 
in other EU countries can be sold and 
grown in Sweden without additional testing.
All seeds sold in Sweden need to be 
certified. To be certified, the variety needs 
to be listed and of good quality in terms of 
germination rate, water content, pathogens 
and have a certain level of purity regarding, 
weed seeds, other seeds, and debris.
The plantbreeders’ rights hold for a 
maximum of 25 to 30 years depending on 
the species. These rights do not, however, 
prevent others from using the protected 
varieties in research, trials, or as parents in 
breeding. For GM crops with patents it is 
the genetic modification that is protected 
by the patent, the variety is protected by the 
plant breeder's right.
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Economic value of GM crops
A large number of studies have found a posi-
tive impact of GM crops on farm income due 
to a combination of enhanced productivity and 
efficiency gains. Estimates put the total cumula-
tive economic impact of GM crops from 1996 
to 2010 at 59 billion euros. The estimate for the 
year 2010 alone is nearly 11 billion euros, or an 
additional 4.3% of the global production value of 
the four main crops of soybeans, maize, rapeseed, 
and cotton.
The benefits to farmers come from higher 
yields and lower input costs. However, draw-
backs to GM crops include higher seed prices 
and potentially lower prices for the final product. 
Added costs due to the need to segregate GM 
foods from conventional foods along the supply 
chain might further burden the food production 
system. The estimated distribution of benefits 
varies according to the methodology applied 
by each researcher. It also depends very much 
on local institutional factors. For example, the 
total benefit from herbicide tolerant soybean is 
estimated to be distributed between consumers 
and the food processing industry (who together 
see 50% of the benefit), farmers (who see 28% of 
the benefit), and the biotech industry (which sees 
22%). Some studies, however, put the benefits to 
the biotech industry at up to 30%–60%. In 2010, 
farmers had to pay 4 billion euros in royalties 
to the biotech companies in order to access this 
technology, and this accounts for an average of 
38% of the estimated benefits to global farm 
income resulting from the application of GM 
crops. 
There is also the issue of market power and 
appropriation of benefits because the intellectual 
property rights belong to a small number of 
firms that can charge high prices for seeds and 
Million hectares of GM crops grown commercially in 2013 per country. (Based on James 2013) 
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thus appropriate a large share of the benefits. In 
a similar manner, the retailers, which are highly 
oligopolistic in most countries, are able to absorb 
a large share of the benefits by exercising their 
market power.
A geographic shift in the benefits of GMO 
applications toward developing countries has 
occurred in recent years. The increase in farm 
income has been larger in developing countries 
compared to developed countries, and this is 
mainly due to the lower baseline income of 
farmers in developing countries. Also, farmers 
in developing countries pay less for royalties due 
to weaker enforcement of intellectual property 
rights in these countries. Farmers in devel-
oping countries paid 20% of their additional 
income to royalties compared to 58% for farmers 
in developed countries. There is increasing 
evidence of a growing black market for GM 
seeds. Farmers in Argentina, for example, have 
produced their own HT soybean seeds and 
refused to pay royalties to Monsanto, the biotech 
company that first developed the seed.
Several studies estimate that the global effects 
from the production of GM crops have led 
to lower food prices than would have been 
possible without the increased supply that these 
crops have provided. In general, however, the 
estimates of the benefits of GM crops vary 
according to the methodologies used in the 
different studies. In particular, there is a problem 
of self-selection bias in the estimates. Farmers 
who adopt GM technology are usually the 
most efficient farmers and have more access to 
Farmers have to pay royalties to the biotech companies in order to access the technology. In 2010, those fees accounted 
for an average of 38% of the estimated benefits (of the application of GM crops) to global farm income.
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information, thus they tend to perform better 
than average regardless of whether they are 
growing GM crops or conventional crops. There 
is also an on-going debate on whether to include 
externalities – such as potential health hazards, 
threats to biodiversity, and loss of traditional 
agronomic practices – in the calculations. These 
are not included in the economic calculations 
cited above.
The approval of new GM crop varieties 
is time consuming and very costly, and the 
asynchronous approval of GM crops, especially 
between the US and Europe, has trade implica-
tions. Due to the different regulatory schemes in 
the two regions, the development and approval 
of new varieties in the US is far faster than in 
the EU. On the whole, biotech firms run a great 
risk when they develop a crop variety, and this 
has significant implications both upstream and 
downstream in the agri-food value chain.
Due to the asynchronicity in the approval 
process, when a biotech firm develops a new 
variety they need to have a strategy as to where 
and when to apply for approval. In their strategy, 
they have to consider not only the countries 
where the cultivation of the GM crop will take 
place but also where it will be imported to and 
eventually consumed. Therefore, they have 
to strategically plan the sequence and timing 
of their applications and to consider the costs 
carefully.
Regulatory systems to handle submissions 
and examinations for cultivation or import 
of GM crops currently exist in 33 countries, 
and most other countries are in the process 
of developing such systems. The differences 
among the regulatory systems are large and 
complicated, and the time and cost required to 
apply for approval can vary widely. The US, 
Canada, Japan, and a few other countries have 
very similar regulatory regimes and approval 
procedures. The EU, however, and some other 
countries have a very cumbersome, costly, and 
slow process of approving new GM crops (see 
page 71). While the EU started to consider 
GM crops as early as 1997, it stopped consid-
ering petitions for regulatory approval in 2001 
when six countries (Austria, France, Greece, 
Hungary, Germany, and Luxembourg) invoked 
a “safeguard clause”*. In 2003, the US, Canada, 
Argentina, and ten other countries filed a 
complaint with the World Trade Organisation 
against the EU moratorium, which was lifted 
in 2004. The EU allowed GMOs only after 
mandatory labelling laws and full traceability of 
GM foods and feeds along the EU supply chain 
were implemented. As it is today, the review 
process takes on average almost twice as long 
in the EU compared to the US. There are no 
accurate estimates of the compliance costs in the 
EU for a new GM variety, but some estimates 
put the cost in the range of 6–12 million euros.
The economic implications of asynchronous 
approval of GM crops can be very significant. 
The widespread cultivation of GM crops that are 
approved in the exporting countries but not in 
the EU has the potential to lead to severe trade 
disruptions. As a consequence, EU livestock 
producers face the risk of being cut off from 
high-quality, protein-rich feed that is difficult to 
produce within the EU in sufficient quantities. 
The resulting loss in competitiveness of the EU 
livestock sector could then have implications for 
agricultural incomes and employment as well as 
effects on upstream and downstream industries. 
Significant increases in meat prices could poten-
tially result in a situation where the EU begins 
to import meat from countries where animals 
are fed on GM crops that the EU producers are 
not allowed to use.
78 
Photo: Latife Yardim
79 
Mistra Biotech 
Mistra Biotech is an interdisciplinary 
research programme focusing on use of bio-
technology for sustainable and competitive 
agriculture and food systems. Our vision is to 
contribute to the processes that will enable the 
Swedish agricultural and food sector to produce 
an increased amount of high-quality, healthy 
food at moderate costs with less inputs, de-
creased environmental impacts, and healthier 
crops and livestock. The goal is sustainable 
production systems from ecological, social, and 
economic perspectives. We perform research in 
both the natural and the social sciences. 
Our research in the natural sciences is aimed 
at utilizing the potential of agricultural biotech-
nology to contribute to more sustainable food 
production.
Our research in the social sciences has its focus 
on the social, economic, and ethical aspects 
of the use of biotechnology in agricultural 
production.
With ability comes responsibility, and we 
take the concerns that have been raised about 
potential negative effects of biotechnological 
breeding applications very seriously. For us, 
safety, control, and transparency are essential 
regardless of which technology is used.
 
Mistra Biotech involves over 50 
researchers, most of whom are employed 
by SLU with some working at KTH, Lund 
University, and other academic institu-
tions. Mistra Biotech is financed by 
the Swedish Foundation for Strategic 
Environmental Research (Mistra) and the 
Swedish University of Agricultural Sciences 
(SLU). Many companies, agencies, and 
organisations support the programme 
with knowledge, expertise, and valuable 
feedback. 
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Allele - Alternative form of a gene.
Allopolyploid - Polyploid with chromosomes derived from different species.
Autopolyploid - Polyploid with multiple chromosome sets derived from a single species.
Chromosome - A structure of DNA and associated proteins. 
Cloning  - Development of an organism from a single somatic cell or nucleus.
Diploids - Organism with two sets of chromosomes.
DNA - Deoxyribonucleic acid. The large molecule that stores the genetic  
  information in all cells.
Endonuclease - Nuclease that cleaves within polynucleotide chains.
Exonuclease - Nuclease that cleaves polynucleotide chains one by one from the ends.
Gamete  -  Haploid reproductive cell produced by meiosis.
Genome - The complete set of genes carried by an organism.
Genotype - The genetic constitution of an organism.
Germ cell - Reproductive cell that give rise to a gamete.
GMO  -  Genetically Modified Organism. An organism in which the genetic material  
  has been altered in a way that does not occur naturally by mating  
  and/or natural recombination.
Haploid - Cell only containing one set of chromosomes (comp. diploid).
Heritability - Proportion of phenotypic variation in a population that  
  depends on genetic variation.
Heterosis - Hybrid vigour, superiority of the offspring in one or more 
  characters over the parents.
Heterozygous - Diploid organism with two different alleles at a given locus.
Hexaploid - Organism with six sets of chromosomes. 
Homozygote - Organism with identical pairs of genes (or alleles) for a specific trait.
Locus - Location of a gene.
Meristem - Tissue in plants containing undifferentiated cells.
Metabolites - Small cell molecules with various functions.
Microspore - Plant spore that develop into male gametophyte and then sperm cell.
Glossary
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miRNA/ - Small non-coding RNA molecules regulating gene expression. 
micro RNA 
Meiosis - Cell division resulting in gametes (egg or sperm) with half the number  
  of chromosomes.
Messenger RNA - RNA molecules that transport genetic information from DNA to the ribosome, 
(mRNA)   where they specify the amino acid sequence of the protein produced.
Mitos - Cell division resulting in two cells with identical sets of chromosomes.
Mutation - A change in the nucleotide sequence in an organism.
Nuclease - Enzyme that cleaves the bonds between nucleotides.
Nucleotide  -  The basic subunits of DNA; adenine, thymine, cytosine, and guanine.  
  And RNA where the thymine is replance by uracil.
Oligonucleotide - Short, single-stranded DNA or RNA molecules.
Phenotype - The result from the expression of an organism’s genes + environmental  
  factors and the interactions between the two.
Plasmid - Short DNA, most commonly found as circular, double-stranded DNA in bacteria.
Polyploid - Organism containing more than two paired (homologous) sets of chromosomes.
QTL - Quantitative trait loci, DNA sequences containing or linked to  
  the genes coding for a quantitative trait.
Ribosome  - The large and complex molecule where mRNA is translated into proteins.
RNA - Ribonucleic acid, a family of molecules that perform coding, decoding,   
  regulation, and expression of genes.
Somatic cell - Cell other than a gamete, germ cell or undifferentiated stem cell.
Totipotent - A cell with the ability to divide and produce all of the differentiated  
  cells in an organism.
Transcription - When DNA is copied to messenger RNA (the first step of gene expression).
Transformation  - Introduction of exogenous DNA into the genome. 
Transgenic - Organism into which genes from another species have been deliberately  
  introduced though genetic modification.
Translation - Decoding of messenger RNA into an amino acid chain that later is folded  
  into a protein.
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SHAPING OUR FOOD…
You may not have thought about why tomatoes look the way they do, why our pets 
and farm animals are so calm and friendly, or how it is possible to get a watermelon 
without any seeds in it. Although the breeding of plants and livestock have shaped 
more or less everything we eat, few people know about the scientific achievements 
and the tedious work that results in the food we see on our plates every day. 
With this book we wish to give an overview of the background of domestication 
and breeding, from the beginning of farming more than 10,000 years ago to the 
molecular work of today. We present the basics of the structures and functions of 
genes, describe why and how different breeding methods are applied to crops and 
livestock, and give some insight into legislation surrounding the use of biotech-
nology in breeding in the EU and in Sweden. We also provide an overview of 
different products produced through genetic modification, a summary of the 
economic impact of such crops, and some ethical issues related to breeding in 
general and to genetic modification in particular.  
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